{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:55:55Z","timestamp":1793825755444,"version":"4.6.1"},"reference-count":360,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-025-00626-1","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T03:02:46Z","timestamp":1750302166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Bacterial vaginosis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-5678","authenticated-orcid":false,"given":"Catriona S.","family":"Bradshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4005-3858","authenticated-orcid":false,"given":"Christina A.","family":"Muzny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9924-2349","authenticated-orcid":false,"given":"Caroline M.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Fredricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-5917","authenticated-orcid":false,"given":"Melissa M.","family":"Herbst-Kralovetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3679-9195","authenticated-orcid":false,"given":"Lenka A.","family":"Vodstrcil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"626_CR1","first-page":"1350","volume":"45","author":"R Schr\u00f6der","year":"1921","unstructured":"Schr\u00f6der, R. Zur pathogenese und klinik des vaginalen fluors. Zentralbl. Gyn\u00e4kol. 45, 1350\u20131361 (1921).","journal-title":"Zentralbl. Gyn\u00e4kol."},{"key":"626_CR2","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/0002-9378(55)90095-8","volume":"69","author":"HL Gardner","year":"1955","unstructured":"Gardner, H. L. & Dukes, C. D. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am. J. Obstet. Gynecol. 69, 962\u2013976 (1955).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"626_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1099\/00207713-30-1-170","volume":"30","author":"JR Greenwood","year":"1980","unstructured":"Greenwood, J. R. & Pickett, M. J. Transfer of Haemophilus vaginalis Gardner and Dukes to a new genus, Gardnerella: G. vaginalis (Gardner and Dukes). Int. J. Syst. Bacteriol. 30, 170\u2013178 (1980).","journal-title":"Int. J. Syst. Bacteriol."},{"key":"626_CR4","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa043802","volume":"353","author":"DN Fredricks","year":"2005","unstructured":"Fredricks, D. N., Fiedler, T. L. & Marrazzo, J. M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353, 1899\u20131911 (2005). Early molecular study to characterize the bacterial composition of the vaginal microbiota using broad-range PCR, which highlighted bacterial diversity in bacterial vaginosis and identified newly recognized species, including three bacteria in the Clostridiales order that were highly specific for bacterial vaginosis.","journal-title":"N. Engl. J. Med."},{"key":"626_CR5","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108, 4680\u20134687 (2011). Early sequencing study that showed the vaginal microbiota of North American women clustered into five groups (community-state types), which have been subsequently widely used to describe the vaginal microbiota within and across populations.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"626_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/QCO.0000000000000620","volume":"33","author":"CA Muzny","year":"2020","unstructured":"Muzny, C. A., Laniewski, P., Schwebke, J. R. & Herbst-Kralovetz, M. M. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr. Opin. Infect. Dis. 33, 59\u201365 (2020). This article includes an updated discussion on the role of host\u2013vaginal microbiota interactions in incident bacterial vaginosis pathogenesis.","journal-title":"Curr. Opin. Infect. Dis."},{"key":"626_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056111","volume":"8","author":"CJ Yeoman","year":"2013","unstructured":"Yeoman, C. J. et al. A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS ONE\u00a08, e56111 (2013).","journal-title":"PLoS ONE"},{"key":"626_CR8","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/infdis\/jiu004","volume":"209","author":"SY Doerflinger","year":"2014","unstructured":"Doerflinger, S. Y., Throop, A. L. & Herbst-Kralovetz, M. M. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J. Infect. Dis. 209, 1989\u20131999 (2014).","journal-title":"J. Infect. Dis."},{"key":"626_CR9","doi-asserted-by":"publisher","first-page":"e00204-15","DOI":"10.1128\/mBio.00204-15","volume":"6","author":"S Srinivasan","year":"2015","unstructured":"Srinivasan, S. et al. Metabolic signatures of bacterial vaginosis. mBio 6, e00204-15 (2015).","journal-title":"mBio"},{"key":"626_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","volume":"42","author":"MN Anahtar","year":"2015","unstructured":"Anahtar, M. N. et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 42, 965\u2013976 (2015).","journal-title":"Immunity"},{"key":"626_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/mi.2015.86","volume":"9","author":"H Borgdorff","year":"2016","unstructured":"Borgdorff, H. et al. Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. Mucosal Immunol. 9, 621\u2013633 (2016).","journal-title":"Mucosal Immunol."},{"key":"626_CR12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/jama.2020.0233","volume":"323","author":"LC Kahwati","year":"2020","unstructured":"Kahwati, L. C. et al. Screening for bacterial vaginosis in pregnant adolescents and women to prevent preterm delivery: updated evidence report and systematic review for the US preventive services task force. JAMA 323, 1293\u20131309 (2020).","journal-title":"JAMA"},{"key":"626_CR13","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","volume":"22","author":"J Atashili","year":"2008","unstructured":"Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A. & Smith, J. S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22, 1493\u20131501 (2008).","journal-title":"AIDS"},{"key":"626_CR14","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1086\/657320","volume":"202","author":"RM Brotman","year":"2010","unstructured":"Brotman, R. M. et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J. Infect. Dis. 202, 1907\u20131915 (2010).","journal-title":"J. Infect. Dis."},{"key":"626_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1086\/375819","volume":"37","author":"TL Cherpes","year":"2003","unstructured":"Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G. & Hillier, S. L. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin. Infect. Dis. 37, 319\u2013325 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150272","volume":"11","author":"J Bilardi","year":"2016","unstructured":"Bilardi, J. et al. Women\u2019s views and experiences of the triggers for onset of bacterial vaginosis and exacerbating factors associated with recurrence. PLoS ONE 11, e0150272 (2016).","journal-title":"PLoS ONE"},{"key":"626_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074378","volume":"8","author":"JE Bilardi","year":"2013","unstructured":"Bilardi, J. E. et al. The burden of bacterial vaginosis: women\u2019s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS ONE 8, e74378 (2013). First study to describe the substantial physical and psychological burden of bacterial vaginosis on women and the impact of not receiving effective curative therapy.","journal-title":"PLoS ONE"},{"key":"626_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","volume":"46","author":"K Peebles","year":"2019","unstructured":"Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S. & Barnabas, R. V. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex. Transm. Dis. 46, 304\u2013311 (2019). Highly cited comprehensive systematic review and meta-analysis describing global and regional prevalence estimates for bacterial vaginosis.","journal-title":"Sex. Transm. Dis."},{"key":"626_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105998","volume":"9","author":"JHHM van de Wijgert","year":"2014","unstructured":"van de Wijgert, J. H. H. M. et al. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS ONE 9, e105998 (2014).","journal-title":"PLoS ONE"},{"key":"626_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002511","volume":"15","author":"EA Torrone","year":"2018","unstructured":"Torrone, E. A. et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med. 15, e1002511 (2018).","journal-title":"PLoS Med."},{"key":"626_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","volume":"9","author":"LG Bekker","year":"2023","unstructured":"Bekker, L. G. et al. HIV infection. Nat. Rev. Dis. Primers\u00a09, 42 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"626_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2180-12-83","volume":"12","author":"V Jespers","year":"2012","unstructured":"Jespers, V. et al. Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests. BMC Microbiol. 12, 83 (2012).","journal-title":"BMC Microbiol."},{"key":"626_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ajog.2018.10.014","volume":"220","author":"L Bayigga","year":"2019","unstructured":"Bayigga, L., Kateete, D. P., Anderson, D. J., Sekikubo, M. & Nakanjako, D. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention. Am. J. Obstet. Gynecol. 220, 155\u2013166 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"626_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10153-1","volume":"24","author":"D Obeid","year":"2024","unstructured":"Obeid, D. et al. Sexually transmitted infections in the middle east and North Africa: comprehensive systematic review and meta-analysis. BMC Infect. Dis. 24, 1229 (2024).","journal-title":"BMC Infect. Dis."},{"key":"626_CR25","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/OLQ.0b013e318074e565","volume":"34","author":"EH Koumans","year":"2007","unstructured":"Koumans, E. H. et al. The prevalence of bacterial vaginosis in the United States, 2001\u20132004; associations with symptoms, sexual behaviors, and reproductive health. Sex. Transm. Dis. 34, 864\u2013869 (2007).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR26","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1099\/mic.0.081034-0","volume":"160","author":"JM Fettweis","year":"2014","unstructured":"Fettweis, J. M. et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology 160, 2272\u20132282 (2014).","journal-title":"Microbiology"},{"key":"626_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ismej.2007.12","volume":"1","author":"X Zhou","year":"2007","unstructured":"Zhou, X. et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J. 1, 121\u2013133 (2007).","journal-title":"ISME J."},{"key":"626_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1503\/cmaj.1031730","volume":"171","author":"WM Wenman","year":"2004","unstructured":"Wenman, W. M., Joffres, M. R., Tataryn, I. V. & Edmonton Perinatal Infections, G. A prospective cohort study of pregnancy risk factors and birth outcomes in Aboriginal women. Can. Med. Assoc. J. 171, 585\u2013589 (2004).","journal-title":"Can. Med. Assoc. J."},{"key":"626_CR29","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/clinids\/21.6.1402","volume":"21","author":"BJ Berger","year":"1995","unstructured":"Berger, B. J. et al. Bacterial vaginosis in lesbians: a sexually transmitted disease. Clin. Infect. Dis. 21, 1402\u20131405 (1995).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR30","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1086\/339884","volume":"185","author":"JM Marrazzo","year":"2002","unstructured":"Marrazzo, J. M. et al. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J. Infect. Dis. 185, 1307\u20131313 (2002).","journal-title":"J. Infect. Dis."},{"key":"626_CR31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/sti.2006.022277","volume":"83","author":"AL Evans","year":"2007","unstructured":"Evans, A. L., Scally, A. J., Wellard, S. J. & Wilson, J. D. Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting. Sex. Transm. Infect. 83, 470\u2013475 (2007).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR32","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/infdis\/jit664","volume":"209","author":"CS Bradshaw","year":"2014","unstructured":"Bradshaw, C. S. et al. The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW health study. J. Infect. Dis. 209, 1562\u20131572 (2014).","journal-title":"J. Infect. Dis."},{"key":"626_CR33","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1001\/jama.2012.3428","volume":"307","author":"RM Chico","year":"2012","unstructured":"Chico, R. M. et al. Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA 307, 2079\u20132086 (2012).","journal-title":"JAMA"},{"key":"626_CR34","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/sextrans-2021-055057","volume":"98","author":"DC Nyemba","year":"2022","unstructured":"Nyemba, D. C. et al. Prevalence of curable STIs and bacterial vaginosis during pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. Sex. Transm. Infect. 98, 484\u2013491 (2022).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR35","first-page":"422","volume":"93","author":"S Tuddenham","year":"2023","unstructured":"Tuddenham, S. et al. Association of pregnancy and HIV status with molecular-bacterial vaginosis in Indian women. J. AIDS 93, 422\u2013430 (2023).","journal-title":"J. AIDS"},{"key":"626_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/bmj.308.6924.295","volume":"308","author":"PE Hay","year":"1994","unstructured":"Hay, P. E. et al. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 308, 295\u2013298 (1994).","journal-title":"BMJ"},{"key":"626_CR37","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00404-018-4722-8","volume":"297","author":"S Sabour","year":"2018","unstructured":"Sabour, S. et al. Prevalence of bacterial vaginosis in pregnant and non-pregnant Iranian women: a systematic review and meta-analysis. Arch. Gynecol. Obstet. 297, 1101\u20131113 (2018).","journal-title":"Arch. Gynecol. Obstet."},{"key":"626_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41564-022-01083-2","volume":"7","author":"M France","year":"2022","unstructured":"France, M., Alizadeh, M., Brown, S., Ma, B. & Ravel, J. Towards a deeper understanding of the vaginal microbiota. Nat. Microbiol. 7, 367\u2013378 (2022).","journal-title":"Nat. Microbiol."},{"key":"626_CR39","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s10096-021-04152-2","volume":"40","author":"W Xiaoming","year":"2021","unstructured":"Xiaoming, W. et al. Characteristics of the vaginal microbiomes in prepubertal girls with and without vulvovaginitis. Eur. J. Clin. Microbiol. Infect. Dis. 40, 1253\u20131261 (2021).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"626_CR40","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1542\/peds.77.4.488","volume":"77","author":"RC Bump","year":"1986","unstructured":"Bump, R. C., Sachs, L. A. & Buesching, W. J. 3rd Sexually transmissible infectious agents in sexually active and virginal asymptomatic adolescent girls. Pediatrics 77, 488\u2013494 (1986).","journal-title":"Pediatrics"},{"key":"626_CR41","doi-asserted-by":"publisher","first-page":"e00097-15","DOI":"10.1128\/mBio.00097-15","volume":"6","author":"RJ Hickey","year":"2015","unstructured":"Hickey, R. J. et al. Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductive-age women. mBio 6, e00097-15 (2015).","journal-title":"mBio"},{"key":"626_CR42","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0022-3476(85)80208-0","volume":"107","author":"MA Shafer","year":"1985","unstructured":"Shafer, M. A. et al. Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J. Pediatr. 107, 974\u2013981 (1985).","journal-title":"J. Pediatr."},{"key":"626_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1542\/peds.2009-0892","volume":"127","author":"RJ DiClemente","year":"2011","unstructured":"DiClemente, R. J., Sales, J. M., Danner, F. & Crosby, R. A. Association between sexually transmitted diseases and young adults\u2019 self-reported abstinence. Pediatrics 127, 208\u2013213 (2011).","journal-title":"Pediatrics"},{"key":"626_CR44","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1086\/323030","volume":"33","author":"AA Aroutcheva","year":"2001","unstructured":"Aroutcheva, A. A., Simoes, J. A., Behbakht, K. & Faro, S. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clin. Infect. Dis. 33, 1022\u20131027 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR45","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/infdis\/jis242","volume":"205","author":"JM Marrazzo","year":"2012","unstructured":"Marrazzo, J. M. et al. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J. Infect. Dis. 205, 1580\u20131588 (2012).","journal-title":"J. Infect. Dis."},{"key":"626_CR46","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/infdis\/jiaa233","volume":"225","author":"DN Fredricks","year":"2022","unstructured":"Fredricks, D. N. et al. Vaginal and extra-vaginal bacterial colonization and risk for incident bacterial vaginosis in a population of women who have sex with men. J. Infect. Dis. 225, 1261\u20131265 (2022).","journal-title":"J. Infect. Dis."},{"key":"626_CR47","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1086\/648092","volume":"200","author":"KA Fethers","year":"2009","unstructured":"Fethers, K. A. et al. Early sexual experiences and risk factors for bacterial vaginosis. J. Infect. Dis. 200, 1662\u20131670 (2009).","journal-title":"J. Infect. Dis."},{"key":"626_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275908","volume":"17","author":"MT France","year":"2022","unstructured":"France, M. T., Brown, S. E., Rompalo, A. M., Brotman, R. M. & Ravel, J. Identification of shared bacterial strains in the vaginal microbiota of related and unrelated reproductive-age mothers and daughters using genome-resolved metagenomics. PLoS ONE 17, e0275908 (2022).","journal-title":"PLoS ONE"},{"key":"626_CR49","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1097\/GME.0000000000000904","volume":"24","author":"CM Mitchell","year":"2017","unstructured":"Mitchell, C. M. et al. Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. Menopause 24, 1160\u20131166 (2017).","journal-title":"Menopause"},{"key":"626_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1071\/SH21083","volume":"19","author":"LL Stewart","year":"2022","unstructured":"Stewart, L. L., Vodstrcil, L. A., Coombe, J., Bradshaw, C. S. & Hocking, J. S. Prevalence of bacterial vaginosis in postmenopausal women: a systematic review and meta-analysis. Sex. Health 19, 17\u201326 (2022).","journal-title":"Sex. Health"},{"key":"626_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02077-3","volume":"19","author":"LA Vodstrcil","year":"2021","unstructured":"Vodstrcil, L. A., Muzny, C. A., Plummer, E. L., Sobel, J. D. & Bradshaw, C. S. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment. BMC Med. 19, 194 (2021). Comprehensive review outlining the body of evidence for reinfection as a driver of bacterial vaginosis recurrence and the need for partner-treatment trials that address the limitations of past studies.","journal-title":"BMC Med."},{"key":"626_CR52","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/sextrans-2018-053824","volume":"95","author":"CA Muzny","year":"2019","unstructured":"Muzny, C. A., Lensing, S. Y., Aaron, K. J. & Schwebke, J. R. Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women. Sex. Transm. Infect. 95, 511\u2013515 (2019). Cohort study that showed that the incubation period for bacterial vaginosis is similar to that of established sexually transmitted infections and described rapid increases in specific BV-associated bacteria preceding incident BV.","journal-title":"Sex. Transm. Infect."},{"key":"626_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/OLQ.0b013e3181f0bc37","volume":"38","author":"KA Fethers","year":"2011","unstructured":"Fethers, K. A. et al. Low incidence of bacterial vaginosis in cohort of young Australian women. Sex. Transm. Dis. 38, 124\u2013126 (2011).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171856","volume":"12","author":"LA Vodstrcil","year":"2017","unstructured":"Vodstrcil, L. A. et al. The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women. PLoS ONE 12, e0171856 (2017).","journal-title":"PLoS ONE"},{"key":"626_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fcimb.2020.00305","volume":"10","author":"SC Francis","year":"2020","unstructured":"Francis, S. C. et al. The vaginal microbiota among adolescent girls in Tanzania around the time of sexual debut. Front. Cell Infect. Microbiol. 10, 305 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"626_CR56","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/095646249100200511","volume":"2","author":"PG Larsson","year":"1991","unstructured":"Larsson, P. G., Platz-Christensen, J. J. & Sundstrom, E. Is bacterial vaginosis a sexually transmitted disease? Int. J. STD AIDS 2, 362\u2013364 (1991).","journal-title":"Int. J. STD AIDS"},{"key":"626_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.olq.0000200551.07573.df","volume":"33","author":"EA Bukusi","year":"2006","unstructured":"Bukusi, E. A. et al. Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex. Transm. Dis. 33, 361\u2013367 (2006).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/sti.2007.026625","volume":"84","author":"TL Cherpes","year":"2008","unstructured":"Cherpes, T. L. et al. Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis. Sex. Transm. Infect. 84, 57\u201361 (2008).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR59","doi-asserted-by":"publisher","first-page":"282.e1\u2013282.e11","DOI":"10.1016\/j.ajog.2023.06.044","volume":"229","author":"AC Roxby","year":"2023","unstructured":"Roxby, A. C. et al. Low prevalence of bacterial vaginosis in Kenyan adolescent girls and rapid incidence after first sex. Am. J. Obst. Gyn. 229, 282.e1\u2013282.e11 (2023).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR60","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/cid\/ciu1130","volume":"60","author":"LA Vodstrcil","year":"2015","unstructured":"Vodstrcil, L. A. et al. Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV. Clin. Infect. Dis. 60, 1042\u20131053 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141905","volume":"10","author":"DS Forcey","year":"2015","unstructured":"Forcey, D. S. et al. Factors associated with bacterial vaginosis among women who have sex with women: a systematic review. PLoS ONE 10, e0141905 (2015).","journal-title":"PLoS ONE"},{"key":"626_CR62","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1086\/592974","volume":"47","author":"KA Fethers","year":"2008","unstructured":"Fethers, K. A., Fairley, C. K., Hocking, J. S., Gurrin, L. C. & Bradshaw, C. S. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin. Infect. Dis. 47, 1426\u20131435 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR63","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw, C. S. et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis. 193, 1478\u20131489 (2006). First cohort study to show that 60% of women experienced recurrence of bacterial vaginosis within 12 months of recommended therapy, and to demonstrate that ongoing exposure to regular partners was strongly associated with recurrence, implicating reinfection.","journal-title":"J. Infect. Dis."},{"key":"626_CR64","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/cid\/cis1030","volume":"56","author":"CS Bradshaw","year":"2013","unstructured":"Bradshaw, C. S. et al. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin. Infect. Dis. 56, 777\u2013786 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39879-8","volume":"9","author":"LA Vodstrcil","year":"2019","unstructured":"Vodstrcil, L. A. et al. Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial. Sci. Rep. 9, 3555 (2019).","journal-title":"Sci. Rep."},{"key":"626_CR66","doi-asserted-by":"publisher","first-page":"42 e41","DOI":"10.1016\/j.ajog.2008.07.069","volume":"200","author":"RH Gray","year":"2009","unstructured":"Gray, R. H. et al. The effects of male circumcision on female partners\u2019 genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am. J. Obst. Gyn. 200, 42 e41\u201342.e47 (2009).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0020-7292(00)00217-4","volume":"70","author":"E Calzolari","year":"2000","unstructured":"Calzolari, E., Masciangelo, R., Milite, V. & Verteramo, R. Bacterial vaginosis and contraceptive methods. Int. J. Gyn. Obst. 70, 341\u2013346 (2000).","journal-title":"Int. J. Gyn. Obst."},{"key":"626_CR68","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/cid\/ciaa703","volume":"73","author":"K Peebles","year":"2021","unstructured":"Peebles, K. et al. Elevated risk of bacterial vaginosis among users of the copper intrauterine device: a prospective longitudinal cohort study. Clin. Infect. Dis. 73, 513\u2013520 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR69","doi-asserted-by":"publisher","first-page":"622.e1","DOI":"10.1016\/j.ajog.2018.02.017","volume":"218","author":"SL Achilles","year":"2018","unstructured":"Achilles, S. L. et al. Impact of contraceptive initiation on vaginal microbiota. Am. J. Obst. Gyn. 218, 622.e1\u2013622.e10 (2018).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073055","volume":"8","author":"LA Vodstrcil","year":"2013","unstructured":"Vodstrcil, L. A. et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS ONE 8, e73055 (2013).","journal-title":"PLoS ONE"},{"key":"626_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.732423","volume":"11","author":"LK Ratten","year":"2021","unstructured":"Ratten, L. K. et al. The effect of exogenous sex steroids on the vaginal microbiota: a systematic review. Front. Cell Infect. Microbiol. 11, 732423 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"626_CR72","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1258\/0956462001916461","volume":"11","author":"D Hellberg","year":"2000","unstructured":"Hellberg, D., Nilsson, S. & Mardh, P. A. Bacterial vaginosis and smoking. Int. J. STD AIDS 11, 603\u2013606 (2000).","journal-title":"Int. J. STD AIDS"},{"key":"626_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-471","volume":"14","author":"RM Brotman","year":"2014","unstructured":"Brotman, R. M. et al. Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect. Dis. 14, 471 (2014).","journal-title":"BMC Infect. Dis."},{"key":"626_CR74","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8349601","volume":"2018","author":"E Ranjit","year":"2018","unstructured":"Ranjit, E., Raghubanshi, B. R., Maskey, S. & Parajuli, P. Prevalence of bacterial vaginosis and its association with risk factors among nonpregnant women: a hospital based study. Int. J. Microbiol. 2018, 8349601 (2018).","journal-title":"Int. J. Microbiol."},{"key":"626_CR75","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/aje\/kwn103","volume":"168","author":"RM Brotman","year":"2008","unstructured":"Brotman, R. M. et al. A longitudinal study of vaginal douching and bacterial vaginosis-a marginal structural modeling analysis. Am. J. Epidemiol. 168, 188\u2013196 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"626_CR76","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/OLQ.0b013e3181bc063c","volume":"37","author":"MA Klebanoff","year":"2010","unstructured":"Klebanoff, M. A. et al. Personal hygienic behaviors and bacterial vaginosis. Sex. Transm. Dis. 37, 94\u201399 (2010).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000416","volume":"8","author":"N Low","year":"2011","unstructured":"Low, N. et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med. 8, e1000416 (2011).","journal-title":"PLoS Med."},{"key":"626_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1882","volume":"7","author":"S Wireko","year":"2024","unstructured":"Wireko, S., Ofosu, M., Agyemang, F., Dankluvi, H. E. & Cobbina, A. E. Vaginal douching and health risks among young women. Health Sci. Rep. 7, e1882 (2024).","journal-title":"Health Sci. Rep."},{"key":"626_CR79","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41591-019-0450-2","volume":"25","author":"JM Fettweis","year":"2019","unstructured":"Fettweis, J. M. et al. The vaginal microbiome and preterm birth. Nat. Med. 25, 1012\u20131021 (2019).","journal-title":"Nat. Med."},{"key":"626_CR80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1067\/mob.2003.339","volume":"189","author":"H Leitich","year":"2003","unstructured":"Leitich, H. et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am. J. Obst. Gyn. 189, 139\u2013147 (2003).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejogrb.2023.08.013","volume":"289","author":"J Kenfack-Zanguim","year":"2023","unstructured":"Kenfack-Zanguim, J. et al. Systematic review and meta-analysis of maternal and fetal outcomes among pregnant women with bacterial vaginosis. Eur. J. Obst. Gyn. Reprod. Biol. 289, 9\u201318 (2023).","journal-title":"Eur. J. Obst. Gyn. Reprod. Biol."},{"key":"626_CR82","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00404-020-05675-3","volume":"302","author":"X Hong","year":"2020","unstructured":"Hong, X. et al. The association between vaginal microbiota and female infertility: a systematic review and meta-analysis. Arch. Gyn. Obst. 302, 569\u2013578 (2020).","journal-title":"Arch. Gyn. Obst."},{"key":"626_CR83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/GCO.0000000000000953","volume":"36","author":"M Maksimovic Celicanin","year":"2024","unstructured":"Maksimovic Celicanin, M., Haahr, T., Humaidan, P. & Skafte-Holm, A. Vaginal dysbiosis \u2014 the association with reproductive outcomes in IVF patients: a systematic review and meta-analysis. Curr. Opin. Obst. Gyn. 36, 155\u2013164 (2024).","journal-title":"Curr. Opin. Obst. Gyn."},{"key":"626_CR84","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bpobgyn.2006.12.005","volume":"21","author":"H Leitich","year":"2007","unstructured":"Leitich, H. & Kiss, H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract. Res. Clin. Obst. Gyn. 21, 375\u2013390 (2007).","journal-title":"Best Pract. Res. Clin. Obst. Gyn."},{"key":"626_CR85","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/aid.2018.0304","volume":"35","author":"LR McKinnon","year":"2019","unstructured":"McKinnon, L. R. et al. The evolving facets of bacterial vaginosis: implications for HIV transmission. AIDS Res. Hum. Retroviruses 35, 219\u2013228 (2019).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"626_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00932-8","volume":"8","author":"A Alisoltani","year":"2020","unstructured":"Alisoltani, A. et al. Microbial function and genital inflammation in young South African women at high risk of HIV infection. Microbiome 8, 165 (2020).","journal-title":"Microbiome"},{"key":"626_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12007-9","volume":"12","author":"U Gudnadottir","year":"2022","unstructured":"Gudnadottir, U. et al. The vaginal microbiome and the risk of preterm birth: a systematic review and network meta-analysis. Sci. Rep. 12, 7926 (2022).","journal-title":"Sci. Rep."},{"key":"626_CR88","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/0002-9378(90)91115-S","volume":"163","author":"DE Soper","year":"1990","unstructured":"Soper, D. E., Bump, R. C. & Hurt, W. G. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am. J. Obst. Gyn. 163, 1016\u20131021 (1990).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR89","first-page":"450","volume":"77","author":"PG Larsson","year":"1991","unstructured":"Larsson, P. G., Platz-Christensen, J. J., Forsum, U. & Pahlson, C. Clue cells in predicting infections after abdominal hysterectomy. Obst. Gyn. 77, 450\u2013452 (1991).","journal-title":"Obst. Gyn."},{"key":"626_CR90","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/0002-9378(92)91838-2","volume":"166","author":"PG Larsson","year":"1992","unstructured":"Larsson, P. G., Platz-Christensen, J. J., Thejls, H., Forsum, U. & Pahlson, C. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. Am. J. Obst. Gyn. 166, 100\u2013103 (1992).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR91","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1155\/S1064744902000133","volume":"10","author":"PG Larsson","year":"2002","unstructured":"Larsson, P. G. & Carlsson, B. Does pre- and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis? Infect. Dis. Obst. Gyn. 10, 133\u2013140 (2002).","journal-title":"Infect. Dis. Obst. Gyn."},{"key":"626_CR92","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/healthcare11091218","volume":"11","author":"A Ziogou","year":"2023","unstructured":"Ziogou, A. et al. Bacterial vaginosis and post-operative pelvic infections. Healthcare 11, 1218 (2023).","journal-title":"Healthcare"},{"key":"626_CR93","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1093\/infdis\/jiab067","volume":"224","author":"CM Mitchell","year":"2021","unstructured":"Mitchell, C. M. et al. Etiology and diagnosis of pelvic inflammatory disease: looking beyond gonorrhea and chlamydia. J. Infect. Dis. 224, S29\u2013S35 (2021).","journal-title":"J. Infect. Dis."},{"key":"626_CR94","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/423963","volume":"39","author":"CL Haggerty","year":"2004","unstructured":"Haggerty, C. L. et al. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin. Infect. Dis. 39, 990\u2013995 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR95","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/sextrans-2015-052285","volume":"92","author":"CL Haggerty","year":"2016","unstructured":"Haggerty, C. L. et al. Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sex. Transm. Infect. 92, 441\u2013446 (2016).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR96","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/aje\/kwi243","volume":"162","author":"RB Ness","year":"2005","unstructured":"Ness, R. B. et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am. J. Epidemiol. 162, 585\u2013590 (2005).","journal-title":"Am. J. Epidemiol."},{"key":"626_CR97","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1093\/infdis\/jiab103","volume":"224","author":"R Turpin","year":"2021","unstructured":"Turpin, R. et al. Bacterial vaginosis and behavioral factors associated with incident pelvic inflammatory disease in the longitudinal study of vaginal flora. J. Infect. Dis. 224, S137\u2013S144 (2021).","journal-title":"J. Infect. Dis."},{"key":"626_CR98","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/sextrans-2021-055260","volume":"98","author":"S Kerry-Barnard","year":"2022","unstructured":"Kerry-Barnard, S. et al. Vaginal microbiota in ethnically diverse young women who did or did not develop pelvic inflammatory disease: community-based prospective study. Sex. Transm. Infect. 98, 503\u2013509 (2022).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009119","volume":"5","author":"AM Hilber","year":"2010","unstructured":"Hilber, A. M. et al. Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS ONE 5, e9119 (2010).","journal-title":"PLoS ONE"},{"key":"626_CR100","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/cid\/ciac938","volume":"76","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Non-Lactobacillus-dominant and polymicrobial vaginal microbiomes are more common in younger South African women and predictive of increased risk of human immunodeficiency virus acquisition. Clin. Infect. Dis. 76, 1372\u20131381 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001251","volume":"9","author":"CR Cohen","year":"2012","unstructured":"Cohen, C. R. et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 9, e1001251 (2012). Landmark study showing that bacterial vaginosis increased the risk of female-to-male transmission of HIV, which had not previously been reported, with substantial implications for HIV transmission in sub-Saharan Africa.","journal-title":"PLoS Med."},{"key":"626_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-4-25","volume":"4","author":"GT Spear","year":"2007","unstructured":"Spear, G. T., St John, E. & Zariffard, M. R. Bacterial vaginosis and human immunodeficiency virus infection. AIDS Res. Ther. 4, 25 (2007).","journal-title":"AIDS Res. Ther."},{"key":"626_CR103","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1086\/322613","volume":"33","author":"S Cu-Uvin","year":"2001","unstructured":"Cu-Uvin, S. et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin. Infect. Dis. 33, 894\u2013896 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR104","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmi.2018.04.019","volume":"25","author":"J Tamarelle","year":"2019","unstructured":"Tamarelle, J. et al. The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis. Clin. Microbiol. Infect. 25, 35\u201347 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"626_CR105","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1097\/OLQ.0000000000001537","volume":"48","author":"AC Sena","year":"2021","unstructured":"Sena, A. C., Goldstein, L. A., Ramirez, G., Parish, A. J. & McClelland, R. S. Bacterial vaginosis and its association with incident Trichomonas vaginalis infections: a systematic review and meta-analysis. Sex. Transm. Dis. 48, e192\u2013e201 (2021).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR106","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/OLQ.0b013e31816fcaf8","volume":"35","author":"MF Gallo","year":"2008","unstructured":"Gallo, M. F. et al. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex. Transm. Dis. 35, 679\u2013685 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR107","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/OLQ.0b013e3181788301","volume":"35","author":"JE Allsworth","year":"2008","unstructured":"Allsworth, J. E., Lewis, V. A. & Peipert, J. F. Viral sexually transmitted infections and bacterial vaginosis: 2001\u20132004 national health and nutrition examination survey data. Sex. Transm. Dis. 35, 791\u2013796 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajog.2018.12.011","volume":"221","author":"N Brusselaers","year":"2019","unstructured":"Brusselaers, N., Shrestha, S., van de Wijgert, J. & Verstraelen, H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am. J. Obst. Gyn. 221, 9\u201318.e18 (2019).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR109","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/1471-0528.15854","volume":"127","author":"J Norenhag","year":"2020","unstructured":"Norenhag, J. et al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG 127, 171\u2013180 (2020).","journal-title":"BJOG"},{"key":"626_CR110","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s44197-024-00201-z","volume":"14","author":"V Mancilla","year":"2024","unstructured":"Mancilla, V., Jimenez, N. R., Bishop, N. S., Flores, M. & Herbst-Kralovetz, M. M. The vaginal microbiota, human papillomavirus infection, and cervical carcinogenesis: a systematic review in the Latina population. J. Epidemiol. Glob. Health 14, 480\u2013497 (2024).","journal-title":"J. Epidemiol. Glob. Health"},{"key":"626_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045201","volume":"7","author":"E Gillet","year":"2012","unstructured":"Gillet, E. et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLoS ONE 7, e45201 (2012).","journal-title":"PLoS ONE"},{"key":"626_CR112","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1089\/pop.2020.0265","volume":"23","author":"H Brown","year":"2020","unstructured":"Brown, H. & Drexler, M. Improving the diagnosis of vulvovaginitis: perspectives to align practice, guidelines, and awareness. Popul. Health Manag. 23, S3\u2013S12 (2020).","journal-title":"Popul. Health Manag."},{"key":"626_CR113","doi-asserted-by":"crossref","unstructured":"Vaginitis in nonpregnant patients: ACOG practice bulletin, number 215. Obst. Gyn. 135, e1\u2013e17 (2020).","DOI":"10.1097\/AOG.0000000000003604"},{"key":"626_CR114","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1086\/315109","volume":"180","author":"MA Antonio","year":"1999","unstructured":"Antonio, M. A., Hawes, S. E. & Hillier, S. L. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 180, 1950\u20131956 (1999).","journal-title":"J. Infect. Dis."},{"key":"626_CR115","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13479","volume":"10","author":"A Ene","year":"2022","unstructured":"Ene, A., Stegman, N., Wolfe, A. & Putonti, C. Genomic insights into Lactobacillus gasseri and Lactobacillus paragasseri. PeerJ 10, e13479 (2022).","journal-title":"PeerJ"},{"key":"626_CR116","doi-asserted-by":"publisher","first-page":"e00560","DOI":"10.1128\/msphere.00560-20","volume":"5","author":"C Putonti","year":"2020","unstructured":"Putonti, C., Shapiro, J. W., Ene, A., Tsibere, O. & Wolfe, A. J. Comparative genomic study of Lactobacillus jensenii and the newly defined Lactobacillus mulieris species identifies species-specific functionality. mSphere 5, e00560-20 (2020).","journal-title":"mSphere"},{"key":"626_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080074","volume":"8","author":"DE O\u2019Hanlon","year":"2013","unstructured":"O\u2019Hanlon, D. E., Moench, T. R. & Cone, R. A. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS ONE 8, e80074 (2013).","journal-title":"PLoS ONE"},{"key":"626_CR118","doi-asserted-by":"publisher","first-page":"132ra152","DOI":"10.1126\/scitranslmed.3003605","volume":"4","author":"P Gajer","year":"2012","unstructured":"Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra152 (2012).","journal-title":"Sci. Transl. Med."},{"key":"626_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62184-8","volume":"10","author":"MT Manhanzva","year":"2020","unstructured":"Manhanzva, M. T. et al. Inflammatory and antimicrobial properties differ between vaginal Lactobacillus isolates from South African women with non-optimal versus optimal microbiota. Sci. Rep. 10, 6196 (2020).","journal-title":"Sci. Rep."},{"key":"626_CR120","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.trsl.2018.12.005","volume":"207","author":"RG Brown","year":"2019","unstructured":"Brown, R. G. et al. Establishment of vaginal microbiota composition in early pregnancy and its association with subsequent preterm prelabor rupture of the fetal membranes. Transl. Res. 207, 30\u201343 (2019).","journal-title":"Transl. Res."},{"key":"626_CR121","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/ismej.2014.26","volume":"8","author":"H Borgdorff","year":"2014","unstructured":"Borgdorff, H. et al. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV\/STI prevalence and genital HIV viral load in African women. ISME J. 8, 1781\u20131793 (2014).","journal-title":"ISME J."},{"key":"626_CR122","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1086\/315127","volume":"180","author":"HL Martin","year":"1999","unstructured":"Martin, H. L. et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180, 1863\u20131868 (1999).","journal-title":"J. Infect. Dis."},{"key":"626_CR123","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/1471-0528.15299","volume":"126","author":"N Tabatabaei","year":"2019","unstructured":"Tabatabaei, N. et al. Vaginal microbiome in early pregnancy and subsequent risk of spontaneous preterm birth: a case-control study. BJOG 126, 349\u2013358 (2019).","journal-title":"BJOG"},{"key":"626_CR124","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11908-023-00798-5","volume":"25","author":"JB Holm","year":"2023","unstructured":"Holm, J. B., Carter, K. A., Ravel, J. & Brotman, R. M. Lactobacillus iners and genital health: molecular clues to an enigmatic vaginal species. Curr. Infect. Dis. Rep. 25, 67\u201375 (2023).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"626_CR125","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tim.2016.11.007","volume":"25","author":"MI Petrova","year":"2017","unstructured":"Petrova, M. I., Reid, G., Vaneechoutte, M. & Lebeer, S. Lactobacillus iners: friend or foe? Trends Microbiol. 25, 182\u2013191 (2017).","journal-title":"Trends Microbiol."},{"key":"626_CR126","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.resmic.2017.09.003","volume":"168","author":"M Vaneechoutte","year":"2017","unstructured":"Vaneechoutte, M. Lactobacillus iners, the unusual suspect. Res. Microbiol. 168, 826\u2013836 (2017).","journal-title":"Res. Microbiol."},{"key":"626_CR127","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fmed.2018.00181","volume":"5","author":"E Amabebe","year":"2018","unstructured":"Amabebe, E. & Anumba, D. O. C. The vaginal microenvironment: the physiologic role of lactobacilli. Front. Med. 5, 181 (2018).","journal-title":"Front. Med."},{"key":"626_CR128","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/1471-0528.14390","volume":"124","author":"SS Witkin","year":"2017","unstructured":"Witkin, S. S. & Linhares, I. M. Why do lactobacilli dominate the human vaginal microbiota? BJOG 124, 606\u2013611 (2017).","journal-title":"BJOG"},{"key":"626_CR129","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fphys.2015.00164","volume":"6","author":"M Aldunate","year":"2015","unstructured":"Aldunate, M. et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front. Physiol. 6, 164 (2015).","journal-title":"Front. Physiol."},{"key":"626_CR130","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/09513590.2017.1407753","volume":"34","author":"K Godha","year":"2018","unstructured":"Godha, K., Tucker, K. M., Biehl, C., Archer, D. F. & Mirkin, S. Human vaginal pH and microbiota: an update. Gyn. Endocrinol. 34, 451\u2013455 (2018).","journal-title":"Gyn. Endocrinol."},{"key":"626_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-200","volume":"11","author":"DE O\u2019Hanlon","year":"2011","unstructured":"O\u2019Hanlon, D. E., Moench, T. R. & Cone, R. A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect. Dis. 11, 200 (2011).","journal-title":"BMC Infect. Dis."},{"key":"626_CR132","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.resmic.2017.04.001","volume":"168","author":"G Tachedjian","year":"2017","unstructured":"Tachedjian, G., Aldunate, M., Bradshaw, C. S. & Cone, R. A. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res. Microbiol. 168, 782\u2013792 (2017).","journal-title":"Res. Microbiol."},{"key":"626_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01337-5","volume":"10","author":"DJ Delgado-Diaz","year":"2022","unstructured":"Delgado-Diaz, D. J. et al. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression. Microbiome 10, 141 (2022).","journal-title":"Microbiome"},{"key":"626_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47172-y","volume":"13","author":"I Schwecht","year":"2023","unstructured":"Schwecht, I., Nazli, A., Gill, B. & Kaushic, C. Lactic acid enhances vaginal epithelial barrier integrity and ameliorates inflammatory effects of dysbiotic short chain fatty acids and HIV-1. Sci. Rep. 13, 20065 (2023).","journal-title":"Sci. Rep."},{"key":"626_CR135","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fcimb.2019.00446","volume":"9","author":"DJ Delgado-Diaz","year":"2019","unstructured":"Delgado-Diaz, D. J. et al. Distinct immune responses elicited from cervicovaginal epithelial cells by lactic acid and short chain fatty acids associated with optimal and non-optimal vaginal microbiota. Front. Cell Infect. Microbiol. 9, 446 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"626_CR136","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/mi.2017.27","volume":"10","author":"AC Hearps","year":"2017","unstructured":"Hearps, A. C. et al. Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition. Mucosal Immunol. 10, 1480\u20131490 (2017).","journal-title":"Mucosal Immunol."},{"key":"626_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38253-4","volume":"9","author":"E Chetwin","year":"2019","unstructured":"Chetwin, E. et al. Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics. Sci. Rep. 9, 1917 (2019).","journal-title":"Sci. Rep."},{"key":"626_CR138","doi-asserted-by":"publisher","first-page":"e01548-","DOI":"10.1128\/mBio.01548-19","volume":"10","author":"VL Edwards","year":"2019","unstructured":"Edwards, V. L. et al. The cervicovaginal microbiota-host interaction modulates Chlamydia trachomatis infection. mBio 10, e01548-19 (2019).","journal-title":"mBio"},{"key":"626_CR139","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/jac\/dkt156","volume":"68","author":"M Aldunate","year":"2013","unstructured":"Aldunate, M. et al. Vaginal concentrations of lactic acid potently inactivate HIV. J. Antimicrob. Chemother. 68, 2015\u20132025 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"626_CR140","doi-asserted-by":"publisher","first-page":"e01084-15","DOI":"10.1128\/mBio.01084-15","volume":"6","author":"KL Nunn","year":"2015","unstructured":"Nunn, K. L. et al. Enhanced trapping of HIV-1 by human cervicovaginal mucus is associated with Lactobacillus crispatus-dominant microbiota. mBio 6, e01084-15 (2015).","journal-title":"mBio"},{"key":"626_CR141","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fmed.2020.00284","volume":"7","author":"Y He","year":"2020","unstructured":"He, Y. et al. Evaluation of the inhibitory effects of Lactobacillus gasseri and Lactobacillus crispatus on the adhesion of seven common lower genital tract infection-causing pathogens to vaginal epithelial cells. Front. Med. 7, 284 (2020).","journal-title":"Front. Med."},{"key":"626_CR142","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/microorganisms9050975","volume":"9","author":"C Foschi","year":"2021","unstructured":"Foschi, C. et al. Lactobacillus crispatus BC1 biosurfactant counteracts the infectivity of Chlamydia trachomatis elementary bodies. Microorganisms 9, 975 (2021).","journal-title":"Microorganisms"},{"key":"626_CR143","doi-asserted-by":"publisher","first-page":"001409","DOI":"10.1099\/mic.0.001409","volume":"169","author":"S Navarro","year":"2023","unstructured":"Navarro, S., Abla, H., Colmer-Hamood, J. A., Ventolini, G. & Hamood, A. N. Under conditions closely mimicking vaginal fluid, Lactobacillus jensenii strain 62B produces a bacteriocin-like inhibitory substance that targets and eliminates Gardnerella species. Microbiology 169, 001409 (2023).","journal-title":"Microbiology"},{"key":"626_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12198-6","volume":"7","author":"V Jespers","year":"2017","unstructured":"Jespers, V. et al. A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa. Sci. Rep. 7, 11974 (2017).","journal-title":"Sci. Rep."},{"key":"626_CR145","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/mi.2015.51","volume":"9","author":"KB Arnold","year":"2016","unstructured":"Arnold, K. B. et al. Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells. Mucosal Immunol. 9, 194\u2013205 (2016).","journal-title":"Mucosal Immunol."},{"key":"626_CR146","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/sextrans-2017-053506","volume":"95","author":"L Masson","year":"2019","unstructured":"Masson, L. et al. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study. Sex. Transm. Infect. 95, 5\u201312 (2019).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR147","doi-asserted-by":"publisher","first-page":"e00410","DOI":"10.1128\/IAI.00410-17","volume":"86","author":"K Lennard","year":"2018","unstructured":"Lennard, K. et al. Microbial composition predicts genital tract inflammation and persistent bacterial vaginosis in South African adolescent females. Infect. Immun. 86, e00410\u2013e00417 (2018).","journal-title":"Infect. Immun."},{"key":"626_CR148","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41522-021-00259-8","volume":"7","author":"P Laniewski","year":"2021","unstructured":"Laniewski, P. & Herbst-Kralovetz, M. M. Bacterial vaginosis and health-associated bacteria modulate the immunometabolic landscape in 3D model of human cervix. npj Biofilms Microb. 7, 88 (2021).","journal-title":"npj Biofilms Microb."},{"key":"626_CR149","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00452-22","volume":"8","author":"NR Jimenez","year":"2023","unstructured":"Jimenez, N. R., Maarsingh, J. D., Laniewski, P. & Herbst-Kralovetz, M. M. Commensal lactobacilli metabolically contribute to cervical epithelial homeostasis in a species-specific manner. mSphere 8, e0045222 (2023).","journal-title":"mSphere"},{"key":"626_CR150","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/humupd\/dmu065","volume":"21","author":"VL Yarbrough","year":"2015","unstructured":"Yarbrough, V. L., Winkle, S. & Herbst-Kralovetz, M. M. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum. Reprod. Update 21, 353\u2013377 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"626_CR151","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jiw121","volume":"214","author":"CA Muzny","year":"2016","unstructured":"Muzny, C. A. & Schwebke, J. R. Pathogenesis of bacterial vaginosis: discussion of current hypotheses. J. Infect. Dis. 214, S1\u2013S5 (2016).","journal-title":"J. Infect. Dis."},{"key":"626_CR152","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0002-9378(88)90078-6","volume":"158","author":"DA Eschenbach","year":"1988","unstructured":"Eschenbach, D. A. et al. Diagnosis and clinical manifestations of bacterial vaginosis. Am. J. Obst. Gyn. 158, 819\u2013828 (1988).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR153","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0002-9378(93)90339-K","volume":"169","author":"GB Hill","year":"1993","unstructured":"Hill, G. B. The microbiology of bacterial vaginosis. Am. J. Obst. Gyn. 169, 450\u2013454 (1993).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR154","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40291-019-00382-5","volume":"23","author":"E Shipitsyna","year":"2019","unstructured":"Shipitsyna, E. et al. Quantitation of all four Gardnerella vaginalis clades detects abnormal vaginal microbiota characteristic of bacterial vaginosis more accurately than putative G. vaginalis sialidase A gene count. Mol. Diagn. Ther. 23, 139\u2013147 (2019).","journal-title":"Mol. Diagn. Ther."},{"key":"626_CR155","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1099\/jmm.0.066407-0","volume":"63","author":"SV Balashov","year":"2014","unstructured":"Balashov, S. V., Mordechai, E., Adelson, M. E. & Gygax, S. E. Identification, quantification and subtyping of Gardnerella vaginalis in noncultured clinical vaginal samples by quantitative PCR. J. Med. Microbiol. 63, 162\u2013175 (2014).","journal-title":"J. Med. Microbiol."},{"key":"626_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2501-y","volume":"17","author":"M Janulaitiene","year":"2017","unstructured":"Janulaitiene, M. et al. Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis. BMC Infect. Dis. 17, 394 (2017).","journal-title":"BMC Infect. Dis."},{"key":"626_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01692-x","volume":"11","author":"JB Holm","year":"2023","unstructured":"Holm, J. B. et al. Integrating compositional and functional content to describe vaginal microbiomes in health and disease. Microbiome 11, 259 (2023).","journal-title":"Microbiome"},{"key":"626_CR158","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1099\/ijsem.0.003200","volume":"69","author":"M Vaneechoutte","year":"2019","unstructured":"Vaneechoutte, M. et al. Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella. Int. J. Syst. Evol. Microbiol. 69, 679\u2013687 (2019).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"626_CR159","doi-asserted-by":"publisher","unstructured":"Sousa, M. et al. Gardnerella pickettii sp. nov. (formerly Gardnerella genomic species 3) and Gardnerella greenwoodii sp. nov. (formerly Gardnerella genomic species 8) isolated from female urinary microbiome. Int. J. Syst. Evol. Microbiol. https:\/\/doi.org\/10.1099\/ijsem.0.006140 (2023).","DOI":"10.1099\/ijsem.0.006140"},{"key":"626_CR160","doi-asserted-by":"publisher","first-page":"813520","DOI":"10.3389\/fcimb.2021.813520","volume":"11","author":"CST Ferreira","year":"2021","unstructured":"Ferreira, C. S. T., Marconi, C., Parada, C., Ravel, J. & da Silva, M. G. Sialidase activity in the cervicovaginal fluid is associated with changes in bacterial components of Lactobacillus-deprived microbiota. Front. Cell Infect. Microbiol. 11, 813520 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"626_CR161","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1128\/JB.01965-07","volume":"190","author":"SE Gelber","year":"2008","unstructured":"Gelber, S. E., Aguilar, J. L., Lewis, K. L. & Ratner, A. J. Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J. Bacteriol. 190, 3896\u20133903 (2008).","journal-title":"J. Bacteriol."},{"key":"626_CR162","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1093\/infdis\/jiae026","volume":"230","author":"MM Munch","year":"2024","unstructured":"Munch, M. M. et al. Gardnerella species and their association with bacterial vaginosis. J. Infect. Dis. 230, e171\u2013e181 (2024).","journal-title":"J. Infect. Dis."},{"key":"626_CR163","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/01.AOG.0000183594.45524.d2","volume":"106","author":"A Swidsinski","year":"2005","unstructured":"Swidsinski, A. et al. Adherent biofilms in bacterial vaginosis. Obst. Gyn. 106, 1013\u20131023 (2005).","journal-title":"Obst. Gyn."},{"key":"626_CR164","doi-asserted-by":"publisher","first-page":"97.e91","DOI":"10.1016\/j.ajog.2007.06.039","volume":"198","author":"A Swidsinski","year":"2008","unstructured":"Swidsinski, A. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am. J. Obst. Gyn. 198, 97.e91\u201396 (2008).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2024.105403","volume":"26","author":"A Swidsinski","year":"2024","unstructured":"Swidsinski, A. et al. Polymicrobial consortia in the pathogenesis of biofilm vaginosis visualized by FISH. Historic review outlining the basic principles of the polymicrobial infection theory. Microbes Infect. 26, 105403 (2024).","journal-title":"Microbes Infect."},{"key":"626_CR166","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrmicro2415","volume":"8","author":"HC Flemming","year":"2010","unstructured":"Flemming, H. C. & Wingender, J. The biofilm matrix. Nat. Rev. Microbiol. 8, 623\u2013633 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"626_CR167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154086","volume":"11","author":"C Gottschick","year":"2016","unstructured":"Gottschick, C. et al. Screening of compounds against Gardnerella vaginalis biofilms. PLoS ONE 11, e0154086 (2016).","journal-title":"PLoS ONE"},{"key":"626_CR168","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00390-22","volume":"91","author":"E Shvartsman","year":"2023","unstructured":"Shvartsman, E., Hill, J. E., Sandstrom, P. & MacDonald, K. S. Gardnerella revisited: species heterogeneity, virulence factors, mucosal immune responses, and contributions to bacterial vaginosis. Infect. Immun. 91, e0039022 (2023).","journal-title":"Infect. Immun."},{"key":"626_CR169","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/infdis\/jiz342","volume":"220","author":"CA Muzny","year":"2019","unstructured":"Muzny, C. A. et al. An updated conceptual model on the pathogenesis of bacterial vaginosis. J. Infect. Dis. 220, 1399\u20131405 (2019). This article presents an updated conceptual model for the pathogenesis of incident bacterial vaginosis that centres on the roles of virulent strains of Gardnerella vaginalis, as well as Prevotella bivia and Fannyhessea vaginae.","journal-title":"J. Infect. Dis."},{"key":"626_CR170","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/infdis\/jiu089","volume":"210","author":"JR Schwebke","year":"2014","unstructured":"Schwebke, J. R., Muzny, C. A. & Josey, W. E. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J. Infect. Dis. 210, 338\u2013343 (2014).","journal-title":"J. Infect. Dis."},{"key":"626_CR171","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/infdis\/175.2.406","volume":"175","author":"V Pybus","year":"1997","unstructured":"Pybus, V. & Onderdonk, A. B. Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J. Infect. Dis. 175, 406\u2013413 (1997).","journal-title":"J. Infect. Dis."},{"key":"626_CR172","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.micinf.2008.01.004","volume":"10","author":"EK Libby","year":"2008","unstructured":"Libby, E. K., Pascal, K. E., Mordechai, E., Adelson, M. E. & Trama, J. P. Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis. Microbes Infect. 10, 439\u2013446 (2008).","journal-title":"Microbes Infect."},{"key":"626_CR173","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213975","volume":"14","author":"S Dabee","year":"2019","unstructured":"Dabee, S. et al. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection. PLoS ONE 14, e0213975 (2019).","journal-title":"PLoS ONE"},{"key":"626_CR174","doi-asserted-by":"publisher","unstructured":"Jimenez, N. R., Mancilla, V., Laniewski, P. & Herbst-Kralovetz, M. M. Immunometabolic contributions of atopobiaceae family members in human Papillomavirus infection, cervical dysplasia and cancer. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiae533 (2024).","DOI":"10.1093\/infdis\/jiae533"},{"key":"626_CR175","first-page":"523","volume":"50","author":"JH Elnaggar","year":"2023","unstructured":"Elnaggar, J. H. et al. Characterization of vaginal microbial community dynamics in the pathogenesis of incident bacterial vaginosis, a pilot study. Sex. Transm. Dis. 50, 523\u2013530 (2023).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR176","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QCO.0000000000000893","volume":"36","author":"A Waltmann","year":"2023","unstructured":"Waltmann, A., Thomas, C. & Duncan, J. A. The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections. Curr. Opin. Infect. Dis. 36, 35\u201348 (2023).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"626_CR177","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107758","volume":"9","author":"Z Gong","year":"2014","unstructured":"Gong, Z., Luna, Y., Yu, P. & Fan, H. Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2. PLoS ONE 9, e107758 (2014).","journal-title":"PLoS ONE"},{"key":"626_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/srep29024","volume":"6","author":"P Nardini","year":"2016","unstructured":"Nardini, P. et al. Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study. Sci. Rep. 6, 29024 (2016).","journal-title":"Sci. Rep."},{"key":"626_CR179","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-0711-10-8","volume":"10","author":"MA Graver","year":"2011","unstructured":"Graver, M. A. & Wade, J. J. The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth. Ann. Clin. Microbiol. Antimicrob. 10, 8 (2011).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"626_CR180","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijmm.2014.04.006","volume":"304","author":"P Mastromarino","year":"2014","unstructured":"Mastromarino, P. et al. Effects of vaginal lactobacilli in Chlamydia trachomatis infection. Int. J. Med. Microbiol. 304, 654\u2013661 (2014).","journal-title":"Int. J. Med. Microbiol."},{"key":"626_CR181","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/infdis\/jiad391","volume":"228","author":"SR Morrill","year":"2023","unstructured":"Morrill, S. R. et al. Gardnerella vaginolysin potentiates glycan molecular mimicry by Neisseria gonorrhoeae. J. Infect. Dis. 228, 1610\u20131620 (2023).","journal-title":"J. Infect. Dis."},{"key":"626_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25879-7","volume":"8","author":"P Laniewski","year":"2018","unstructured":"Laniewski, P. et al. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci. Rep. 8, 7593 (2018).","journal-title":"Sci. Rep."},{"key":"626_CR183","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41585-020-0286-z","volume":"17","author":"P \u0141aniewski","year":"2020","unstructured":"\u0141aniewski, P., Ilhan, Z. E. & Herbst-Kralovetz, M. M. The microbiome and gynaecological cancer development, prevention and therapy. Nat. Rev. Urol. 17, 232\u2013250 (2020).","journal-title":"Nat. Rev. Urol."},{"key":"626_CR184","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1158\/1940-6207.CAPR-24-0286","volume":"17","author":"P Laniewski","year":"2024","unstructured":"Laniewski, P. et al. Viewing Native American cervical cancer disparities through the lens of the vaginal microbiome: a pilot study. Cancer Prev. Res. 17, 525\u2013538 (2024).","journal-title":"Cancer Prev. Res."},{"key":"626_CR185","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/OLQ.0b013e31827c5a5b","volume":"40","author":"BD Taylor","year":"2013","unstructured":"Taylor, B. D., Darville, T. & Haggerty, C. L. Does bacterial vaginosis cause pelvic inflammatory disease? Sex. Transm. Dis. 40, 117\u2013122 (2013).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR186","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2613.2011.00768.x","volume":"92","author":"D Taylor-Robinson","year":"2011","unstructured":"Taylor-Robinson, D. & Boustouller, Y. L. Damage to oviduct organ cultures by Gardnerella vaginalis. Int. J. Exp. Pathol. 92, 260\u2013265 (2011).","journal-title":"Int. J. Exp. Pathol."},{"key":"626_CR187","first-page":"359","volume":"10","author":"BR Moller","year":"1983","unstructured":"Moller, B. R. & Freundt, E. A. Monkey animal model for study of mycoplasmal infections of the urogenital tract. Sex. Transm. Dis. 10, 359\u2013362 (1983).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR188","doi-asserted-by":"publisher","unstructured":"Eisenberg, T. et al. Sneathia vaginalis sp. nov. (Fusobacteriales, Leptotrichiaceae) as a replacement of the species \u2018Sneathia amnii\u2019 Harwich et al. 2012 and \u2018Leptotrichia amnionii\u2019 Shukla et al. 2002, and emended description of Sneathia (Collins et al. 2001). Int. J. Syst. Evol. Microbiol. https:\/\/doi.org\/10.1099\/ijsem.0.004663 (2019).","DOI":"10.1099\/ijsem.0.004663"},{"key":"626_CR189","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/sti.2008.032821","volume":"85","author":"CL Haggerty","year":"2009","unstructured":"Haggerty, C. L. et al. Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex. Transm. Infect. 85, 242\u2013248 (2009).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR190","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053997","volume":"8","author":"A Swidsinski","year":"2013","unstructured":"Swidsinski, A. et al. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PLoS ONE 8, e53997 (2013).","journal-title":"PLoS ONE"},{"key":"626_CR191","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.siny.2011.10.001","volume":"17","author":"DB DiGiulio","year":"2012","unstructured":"DiGiulio, D. B. Diversity of microbes in amniotic fluid. Sem. Fetal Neonatal Med. 17, 2\u201311 (2012).","journal-title":"Sem. Fetal Neonatal Med."},{"key":"626_CR192","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-0897.2010.00830.x","volume":"64","author":"DB DiGiulio","year":"2010","unstructured":"DiGiulio, D. B. et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am. J. Reprod. Immunol. 64, 38\u201357 (2010).","journal-title":"Am. J. Reprod. Immunol."},{"key":"626_CR193","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.1093\/clinids\/20.Supplement_2.S276","volume":"20","author":"SL Hillier","year":"1995","unstructured":"Hillier, S. L. et al. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin. Infect. Dis. 20, S276\u2013S278 (1995).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR194","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/0002-9378(84)90558-1","volume":"148","author":"CJ Wahbeh","year":"1984","unstructured":"Wahbeh, C. J., Hill, G. B., Eden, R. D. & Gall, S. A. Intra-amniotic bacterial colonization in premature labor. Am. J. Obst. Gyn. 148, 739\u2013743 (1984).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR195","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJM200005183422007","volume":"342","author":"RL Goldenberg","year":"2000","unstructured":"Goldenberg, R. L., Hauth, J. C. & Andrews, W. W. Intrauterine infection and preterm delivery. N. Engl. J. Med. 342, 1500\u20131507 (2000).","journal-title":"N. Engl. J. Med."},{"key":"626_CR196","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.siny.2011.09.001","volume":"17","author":"V Agrawal","year":"2012","unstructured":"Agrawal, V. & Hirsch, E. Intrauterine infection and preterm labor. Sem. Fetal Neonatal Med. 17, 12\u201319 (2012).","journal-title":"Sem. Fetal Neonatal Med."},{"key":"626_CR197","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1515\/JPM.2009.026","volume":"37","author":"DB Nelson","year":"2009","unstructured":"Nelson, D. B. et al. Preterm labor and bacterial vaginosis-associated bacteria among urban women. J. Perinatal Med. 37, 130\u2013134 (2009).","journal-title":"J. Perinatal Med."},{"key":"626_CR198","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41522-022-00270-7","volume":"8","author":"KV Lithgow","year":"2022","unstructured":"Lithgow, K. V. et al. Protease activities of vaginal Porphyromonas species disrupt coagulation and extracellular matrix in the cervicovaginal niche. npj Biofilms Microb. 8, 8 (2022).","journal-title":"npj Biofilms Microb."},{"key":"626_CR199","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0002-9378(93)90342-G","volume":"169","author":"JA McGregor","year":"1993","unstructured":"McGregor, J. A., French, J. I. & Seo, K. Premature rupture of membranes and bacterial vaginosis. Am. J. Obst. Gyn. 169, 463\u2013466 (1993).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR200","first-page":"487","volume":"57","author":"SJ Skinner","year":"1981","unstructured":"Skinner, S. J., Campos, G. A. & Liggins, G. C. Collagen content of human amniotic membranes: effect of gestation length and premature rupture. Obst. Gyn. 57, 487\u2013489 (1981).","journal-title":"Obst. Gyn."},{"key":"626_CR201","doi-asserted-by":"publisher","first-page":"142.e141","DOI":"10.1016\/j.ajog.2010.08.061","volume":"204","author":"S Cauci","year":"2011","unstructured":"Cauci, S. & Culhane, J. F. High sialidase levels increase preterm birth risk among women who are bacterial vaginosis-positive in early gestation. Am. J. Obst. Gyn. 204, 142.e141\u2013142.e149 (2011).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR202","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0002-9378(94)70098-2","volume":"170","author":"JA McGregor","year":"1994","unstructured":"McGregor, J. A. et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am. J. Obst. Gyn. 170, 1048\u20131059 (1994).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR203","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ajog.2004.07.023","volume":"192","author":"S Cauci","year":"2005","unstructured":"Cauci, S., McGregor, J., Thorsen, P., Grove, J. & Guaschino, S. Combination of vaginal pH with vaginal sialidase and prolidase activities for prediction of low birth weight and preterm birth. Am. J. Obst. Gyn. 192, 489\u2013496 (2005).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR204","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0002-9378(99)70609-5","volume":"180","author":"WW Andrews","year":"1999","unstructured":"Andrews, W. W. et al. The preterm prediction study: failure of midtrimester cervical sialidase level elevation to predict subsequent spontaneous preterm birth. Am. J. Obst. Gyn. 180, 1151\u20131154 (1999).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR205","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41522-021-00261-0","volume":"7","author":"S Ng","year":"2021","unstructured":"Ng, S. et al. Large-scale characterisation of the pregnancy vaginal microbiome and sialidase activity in a low-risk Chinese population. npj Biofilms Microb. 7, 89 (2021).","journal-title":"npj Biofilms Microb."},{"key":"626_CR206","first-page":"806","volume":"46","author":"SD Spandorfer","year":"2001","unstructured":"Spandorfer, S. D., Neuer, A., Giraldo, P. C., Rosenwaks, Z. & Witkin, S. S. Relationship of abnormal vaginal flora, proinflammatory cytokines and idiopathic infertility in women undergoing IVF. J. Reprod. Med. 46, 806\u2013810 (2001).","journal-title":"J. Reprod. Med."},{"key":"626_CR207","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/infdis\/167.3.783","volume":"167","author":"JD Sobel","year":"1993","unstructured":"Sobel, J. D., Schmitt, C. & Meriwether, C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J. Infect. Dis. 167, 783\u2013784 (1993).","journal-title":"J. Infect. Dis."},{"key":"626_CR208","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036298","volume":"7","author":"DE Nelson","year":"2012","unstructured":"Nelson, D. E. et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS ONE 7, e36298 (2012).","journal-title":"PLoS ONE"},{"key":"626_CR209","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190199","volume":"13","author":"EL Plummer","year":"2018","unstructured":"Plummer, E. L. et al. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: acceptability, tolerability and impact on the genital microbiota of couples \u2014 a pilot study. PLoS ONE 13, e0190199 (2018).","journal-title":"PLoS ONE"},{"key":"626_CR210","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02323-21","volume":"12","author":"EL Plummer","year":"2021","unstructured":"Plummer, E. L. et al. A prospective, open-label pilot study of concurrent male partner treatment for bacterial vaginosis. mBio 12, e02323-21 (2021).","journal-title":"mBio"},{"key":"626_CR211","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02213-22","volume":"13","author":"EL Plummer","year":"2022","unstructured":"Plummer, E. L. et al. The urethral microbiota of men with and without idiopathic urethritis. mBio 13, e02213-22 (2022).","journal-title":"mBio"},{"key":"626_CR212","first-page":"317","volume":"99","author":"KA Zinsli","year":"2023","unstructured":"Zinsli, K. A. et al. Bacterial vaginosis-associated bacteria in cisgender men who have sex with women: prevalence, association with non-gonococcal urethritis and natural history. Sex. Transm. Infect. 99, 317\u2013323 (2023).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR213","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fcimb.2020.00433","volume":"10","author":"SD Mehta","year":"2020","unstructured":"Mehta, S. D. et al. The microbiome composition of a man\u2019s penis predicts incident bacterial vaginosis in his female sex partner with high accuracy. Front. Cell Infect. Microbiol. 10, 433 (2020). Important study demonstrating that the composition of the penile microbiome, and specifically a penile microbiota dominated by BV-associated bacteria, predicts acquisition of bacterial vaginosis in their female partner.","journal-title":"Front. Cell Infect. Microbiol."},{"key":"626_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100981","volume":"4","author":"E Toh","year":"2023","unstructured":"Toh, E. et al. Sexual behavior shapes male genitourinary microbiome composition. Cell Rep. Med. 4, 100981 (2023).","journal-title":"Cell Rep. Med."},{"key":"626_CR215","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00589-15","volume":"6","author":"CM Liu","year":"2015","unstructured":"Liu, C. M. et al. Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda. mBio 6, e00589-15 (2015). Key study that showed Nugent-scored BV in a female partner to be significantly associated with detection of BV-associated bacteria and BV community state types in the penile microbiota of their male partners, supporting the exchange of BV-associated bacteria during sex and an explanation for BV recurrence and persistence.","journal-title":"mBio"},{"key":"626_CR216","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0161-6","volume":"4","author":"M Zozaya","year":"2016","unstructured":"Zozaya, M. et al. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome 4, 16 (2016).","journal-title":"Microbiome"},{"key":"626_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026732","volume":"6","author":"AM Eren","year":"2011","unstructured":"Eren, A. M. et al. Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS ONE 6, e26732 (2011).","journal-title":"PLoS ONE"},{"key":"626_CR218","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1086\/596632","volume":"199","author":"JM Marrazzo","year":"2009","unstructured":"Marrazzo, J. M., Antonio, M., Agnew, K. & Hillier, S. L. Distribution of genital Lactobacillus strains shared by female sex partners. J. Infect. Dis. 199, 680\u2013683 (2009).","journal-title":"J. Infect. Dis."},{"key":"626_CR219","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa2405404","volume":"392","author":"LA Vodstrcil","year":"2025","unstructured":"Vodstrcil, L. A. et al. Male-partner treatment to prevent recurrence of bacterial vaginosis. N. Engl. J. Med. 392, 947\u2013957 (2025). Landmark randomized controlled trial that found that treating male partners with oral metronidazole and topical clindamycin cream for 7\u2009days while their female partner was being treated for bacterial vaginosis significantly reduced bacterial vaginosis recurrence over 12\u2009weeks of follow-up.","journal-title":"N. Engl. J. Med."},{"key":"626_CR220","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1361825","volume":"2020","author":"T Li","year":"2020","unstructured":"Li, T. et al. Antimicrobial susceptibility testing of metronidazole and clindamycin against Gardnerella vaginalis in planktonic and biofilm formation. Can. J. Infect. Dis. Med. Microbiol. 2020, 1361825 (2020).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"626_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2022.100101","volume":"5","author":"W Johnston","year":"2023","unstructured":"Johnston, W. et al. In vitro bacterial vaginosis biofilm community manipulation using endolysin therapy. Biofilm 5, 100101 (2023).","journal-title":"Biofilm"},{"key":"626_CR222","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1093\/infdis\/jiae134","volume":"230","author":"M Gao","year":"2024","unstructured":"Gao, M., Manos, J., Whiteley, G. & Zablotska-Manos, I. Antibiofilm agents for the treatment and prevention of bacterial vaginosis: a systematic narrative review. J. Infect. Dis. 230, e508\u2013e517 (2024).","journal-title":"J. Infect. Dis."},{"key":"626_CR223","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ajog.2004.05.033","volume":"191","author":"RH Beigi","year":"2004","unstructured":"Beigi, R. H., Austin, M. N., Meyn, L. A., Krohn, M. A. & Hillier, S. L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am. J. Obst. Gyn. 191, 1124\u20131129 (2004).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR224","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1128\/JCM.43.9.4492-4497.2005","volume":"43","author":"MN Austin","year":"2005","unstructured":"Austin, M. N., Beigi, R. H., Meyn, L. A. & Hillier, S. L. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J. Clin. Microbiol. 43, 4492\u20134497 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR225","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-51","volume":"6","author":"E De Backer","year":"2006","unstructured":"De Backer, E. et al. Antibiotic susceptibility of Atopobium vaginae. BMC Infect. Dis. 6, 51 (2006).","journal-title":"BMC Infect. Dis."},{"key":"626_CR226","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-4-5","volume":"4","author":"MJ Ferris","year":"2004","unstructured":"Ferris, M. J. et al. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis. 4, 5 (2004).","journal-title":"BMC Infect. Dis."},{"key":"626_CR227","first-page":"155","volume":"26","author":"P Nagaraja","year":"2008","unstructured":"Nagaraja, P. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis. Ind. J. Med. Microbiol. 26, 155\u2013157 (2008).","journal-title":"Ind. J. Med. Microbiol."},{"key":"626_CR228","first-page":"455","volume":"74","author":"RM Bannatyne","year":"1998","unstructured":"Bannatyne, R. M. & Smith, A. M. Recurrent bacterial vaginosis and metronidazole resistance in Gardnerella vaginalis. Sex. Transm. Infect. 74, 455\u2013456 (1998).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR229","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","volume":"47","author":"MAB Petrina","year":"2017","unstructured":"Petrina, M. A. B., Cosentino, L. A., Rabe, L. K. & Hillier, S. L. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe 47, 115\u2013119 (2017).","journal-title":"Anaerobe"},{"key":"626_CR230","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2015.10.006","volume":"84","author":"JA Schuyler","year":"2016","unstructured":"Schuyler, J. A. et al. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn. Microbiol. Infect. Dis. 84, 1\u20133 (2016).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"626_CR231","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/infdis\/jiv079","volume":"212","author":"BT Mayer","year":"2015","unstructured":"Mayer, B. T. et al. Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis. J. Infect. Dis. 212, 793\u2013802 (2015).","journal-title":"J. Infect. Dis."},{"key":"626_CR232","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010197","volume":"5","author":"S Srinivasan","year":"2010","unstructured":"Srinivasan, S. et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE 5, e10197 (2010).","journal-title":"PLoS ONE"},{"key":"626_CR233","doi-asserted-by":"publisher","first-page":"157.e1","DOI":"10.1016\/j.ajog.2019.08.008","volume":"222","author":"MC Verwijs","year":"2020","unstructured":"Verwijs, M. C., Agaba, S. K., Darby, A. C. & van de Wijgert, J. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. Am. J. Obst. Gyn. 222, 157.e1\u2013157.e13 (2020).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36002-4","volume":"14","author":"BP Brown","year":"2023","unstructured":"Brown, B. P. et al. Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial. Nat. Commun. 14, 499 (2023).","journal-title":"Nat. Commun."},{"key":"626_CR235","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3201\/eid0702.010226","volume":"7","author":"RM Donlan","year":"2001","unstructured":"Donlan, R. M. Biofilms and device-associated infections. Emerg. Infect. Dis. 7, 277\u2013281 (2001).","journal-title":"Emerg. Infect. Dis."},{"key":"626_CR236","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12941-018-0293-6","volume":"17","author":"A Adam","year":"2018","unstructured":"Adam, A. et al. Culture- and PCR-based detection of BV associated microbiological profile of the removed IUDs and correlation with the time period of IUD in place and the presence of the symptoms of genital tract infection. Ann. Clin. Microbiol. Antimicrob. 17, 40 (2018).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"626_CR237","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","volume":"74","author":"R Amsel","year":"1983","unstructured":"Amsel, R. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14\u201322 (1983).","journal-title":"Am. J. Med."},{"key":"626_CR238","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41746-023-00815-w","volume":"6","author":"A Lev-Sagie","year":"2023","unstructured":"Lev-Sagie, A., Strauss, D. & Ben Chetrit, A. Diagnostic performance of an automated microscopy and pH test for diagnosis of vaginitis. npj Digital Med. 6, 66 (2023).","journal-title":"npj Digital Med."},{"key":"626_CR239","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent, R. P., Krohn, M. A. & Hillier, S. L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J. Clin. Microbiol. 29, 297\u2013301 (1991).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR240","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fcimb.2020.00117","volume":"10","author":"JB Holm","year":"2020","unstructured":"Holm, J. B. et al. Comparative metagenome-assembled genome analysis of \u201cCandidatus Lachnocurva vaginae\u201d, formerly known as bacterial vaginosis-associated bacterium-1 (BVAB1). Front. Cell Infect. Microbiol. 10, 117 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"626_CR241","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078633","volume":"8","author":"S Srinivasan","year":"2013","unstructured":"Srinivasan, S. et al. More than meets the eye: associations of vaginal bacteria with Gram stain morphotypes using molecular phylogenetic analysis. PLoS ONE 8, e78633 (2013).","journal-title":"PLoS ONE"},{"key":"626_CR242","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/humrep\/dew026","volume":"31","author":"T Haahr","year":"2016","unstructured":"Haahr, T. et al. Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. Hum. Reprod. 31, 795\u2013803 (2016).","journal-title":"Hum. Reprod."},{"key":"626_CR243","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/sti.78.6.413","volume":"78","author":"CA Ison","year":"2002","unstructured":"Ison, C. A. & Hay, P. E. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex. Transm. Infect. 78, 413\u2013415 (2002).","journal-title":"Sex. Transm. Infect."},{"key":"626_CR244","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1128\/JCM.43.3.1304-1308.2005","volume":"43","author":"CS Bradshaw","year":"2005","unstructured":"Bradshaw, C. S. et al. Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J. Clin. Microbiol. 43, 1304\u20131308 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR245","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1128\/jcm.32.1.148-152.1994","volume":"32","author":"AM Briselden","year":"1994","unstructured":"Briselden, A. M. & Hillier, S. L. Evaluation of affirm VP microbial identification test for Gardnerella vaginalis and Trichomonas vaginalis. J. Clin. Microbiol. 32, 148\u2013152 (1994).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR246","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1128\/JCM.01537-13","volume":"51","author":"CP Cartwright","year":"2013","unstructured":"Cartwright, C. P. et al. Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women. J. Clin. Microbiol. 51, 3694\u20133699 (2013).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR247","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10096-019-03694-w","volume":"39","author":"A Thompson","year":"2020","unstructured":"Thompson, A., Timm, K., Borders, N., Montoya, L. & Culbreath, K. Diagnostic performance of two molecular assays for the detection of vaginitis in symptomatic women. Eur. J. Clin. Microbiol. Infect. Dis. 39, 39\u201344 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"626_CR248","doi-asserted-by":"publisher","first-page":"e00252","DOI":"10.1128\/JCM.00252-18","volume":"56","author":"JR Schwebke","year":"2018","unstructured":"Schwebke, J. R. et al. Diagnostic performance of a molecular test versus clinician assessment of vaginitis. J. Clin. Microbiol. 56, e00252\u201318 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR249","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/AOG.0000000000002090","volume":"130","author":"CA Gaydos","year":"2017","unstructured":"Gaydos, C. A. et al. Clinical validation of a test for the diagnosis of vaginitis. Obstet. Gynecol. 130, 181\u2013189 (2017).","journal-title":"Obstet. Gynecol."},{"key":"626_CR250","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01748-22","volume":"61","author":"RA Lillis","year":"2023","unstructured":"Lillis, R. A. et al. Clinical evaluation of a new molecular test for the detection of organisms causing vaginitis and vaginosis. J. Clin. Microbiol. 61, e0174822 (2023).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR251","doi-asserted-by":"publisher","first-page":"e01643","DOI":"10.1128\/JCM.01643-19","volume":"58","author":"JR Schwebke","year":"2020","unstructured":"Schwebke, J. R. et al. Clinical validation of the Aptima bacterial vaginosis and Aptima Candida\/Trichomonas vaginitis assays: results from a prospective multicenter clinical study. J. Clin. Microbiol. 58, e01643\u201319 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR252","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3390\/diagnostics14182039","volume":"14","author":"K Thomas-White","year":"2024","unstructured":"Thomas-White, K. et al. A metagenomics pipeline to characterize self-collected vaginal microbiome samples. Diagnostics 14, 2039 (2024).","journal-title":"Diagnostics"},{"key":"626_CR253","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.adk4271","volume":"383","author":"DE Hoffmann","year":"2024","unstructured":"Hoffmann, D. E. et al. The DTC microbiome testing industry needs more regulation. Science 383, 1176\u20131179 (2024).","journal-title":"Science"},{"key":"626_CR254","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/infdis\/jiaa675","volume":"223","author":"CM Mitchell","year":"2021","unstructured":"Mitchell, C. M. et al. Bacterial communities associated with abnormal nugent score in postmenopausal versus premenopausal women. J. Infect. Dis. 223, 2048\u20132052 (2021).","journal-title":"J. Infect. Dis."},{"key":"626_CR255","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/j.1365-2672.2012.05384.x","volume":"113","author":"C Schrader","year":"2012","unstructured":"Schrader, C., Schielke, A., Ellerbroek, L. & Johne, R. PCR inhibitors \u2014 occurrence, properties and removal. J. Appl. Microbiol. 113, 1014\u20131026 (2012).","journal-title":"J. Appl. Microbiol."},{"key":"626_CR256","first-page":"570","volume":"79","author":"M Domeika","year":"2000","unstructured":"Domeika, M. & Drulyte, O. Use of PCR for the detection of genital Chlamydia trachomatis infection on self-obtained mailed vaginal samples. Acta Obst. Gyn. Scand. 79, 570\u2013575 (2000).","journal-title":"Acta Obst. Gyn. Scand."},{"key":"626_CR257","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1128\/JCM.36.8.2356-2358.1998","volume":"36","author":"B Toye","year":"1998","unstructured":"Toye, B., Woods, W., Bobrowska, M. & Ramotar, K. Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing. J. Clin. Microbiol. 36, 2356\u20132358 (1998).","journal-title":"J. Clin. Microbiol."},{"key":"626_CR258","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68948-w","volume":"14","author":"D Amitai Komem","year":"2024","unstructured":"Amitai Komem, D. et al. Lubricating gel influence on vaginal microbiome sampling. Sci. Rep. 14, 18223 (2024).","journal-title":"Sci. Rep."},{"key":"626_CR259","first-page":"390","volume":"79","author":"PG Larsson","year":"2000","unstructured":"Larsson, P. G. et al. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study. Acta Obst. Gyn. Scand. 79, 390\u2013396 (2000).","journal-title":"Acta Obst. Gyn. Scand."},{"key":"626_CR260","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJM200002243420802","volume":"342","author":"JC Carey","year":"2000","unstructured":"Carey, J. C. et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N. Engl. J. Med. 342, 534\u2013540 (2000).","journal-title":"N. Engl. J. Med."},{"key":"626_CR261","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1471-0528.2000.tb11660.x","volume":"107","author":"M Kurkinen-Raty","year":"2000","unstructured":"Kurkinen-Raty, M. et al. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 107, 1427\u20131432 (2000).","journal-title":"BJOG"},{"key":"626_CR262","first-page":"643","volume":"97","author":"M Kekki","year":"2001","unstructured":"Kekki, M. et al. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obst. Gyn. 97, 643\u2013648 (2001).","journal-title":"Obst. Gyn."},{"key":"626_CR263","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/1471-0528.15290","volume":"125","author":"MB Bellad","year":"2018","unstructured":"Bellad, M. B. et al. Clindamycin to reduce preterm birth in a low resource setting: a randomised placebo-controlled clinical trial. BJOG 125, 1601\u20131609 (2018).","journal-title":"BJOG"},{"key":"626_CR264","volume":"2013","author":"P Brocklehurst","year":"2013","unstructured":"Brocklehurst, P., Gordon, A., Heatley, E. & Milan, S. J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst. Rev. 2013, CD000262 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"626_CR265","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/aogs.12933","volume":"95","author":"T Haahr","year":"2016","unstructured":"Haahr, T. et al. Treatment of bacterial vaginosis in pregnancy in order to reduce the risk of spontaneous preterm delivery \u2014 a clinical recommendation. Acta Obst. Gyn. Scand. 95, 850\u2013860 (2016).","journal-title":"Acta Obst. Gyn. Scand."},{"key":"626_CR266","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/S0140-6736(18)31617-9","volume":"392","author":"D Subtil","year":"2018","unstructured":"Subtil, D. et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet 392, 2171\u20132179 (2018).","journal-title":"Lancet"},{"key":"626_CR267","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/jamapediatrics.2023.2250","volume":"177","author":"F Bretelle","year":"2023","unstructured":"Bretelle, F. et al. Effectiveness and costs of molecular screening and treatment for bacterial vaginosis to prevent preterm birth: the AuTop randomized clinical trial. JAMA Pediat. 177, 894\u2013902 (2023).","journal-title":"JAMA Pediat."},{"key":"626_CR268","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/bmj.38169.519653.EB","volume":"329","author":"H Kiss","year":"2004","unstructured":"Kiss, H., Petricevic, L. & Husslein, P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 329, 371 (2004).","journal-title":"BMJ"},{"key":"626_CR269","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2020.2684","volume":"323","author":"DK Owens","year":"2020","unstructured":"Owens, D. K. et al. Screening for bacterial vaginosis in pregnant persons to prevent preterm delivery: US preventive services task force recommendation statement. JAMA 323, 1286\u20131292 (2020).","journal-title":"JAMA"},{"key":"626_CR270","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1915254","volume":"382","author":"CR Cohen","year":"2020","unstructured":"Cohen, C. R. et al. Randomized trial of lactin-V to prevent recurrence of bacterial vaginosis. N. Engl. J. Med. 382, 1906\u20131915 (2020).","journal-title":"N. Engl. J. Med."},{"key":"626_CR271","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/0956462418785451","volume":"29","author":"J Sherrard","year":"2018","unstructured":"Sherrard, J., Wilson, J., Donders, G., Mendling, W. & Jensen, J. S. 2018 European (IUSTI\/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS 29, 1258\u20131272 (2018).","journal-title":"Int. J. STD AIDS"},{"key":"626_CR272","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski, K. A. et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm. Rep. 70, 1\u2013187 (2021).","journal-title":"MMWR Recomm. Rep."},{"key":"626_CR273","unstructured":"Guidelines for the management of symptomatic sexually transmitted infections. World Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240024168 (2021)."},{"key":"626_CR274","unstructured":"STI testing and management advice has changed. Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM) http:\/\/www.sti.guidelines.org.au\/ (2021)."},{"key":"626_CR275","doi-asserted-by":"crossref","unstructured":"Bacterial Vaginosis 2012. British Association for Sexual Health and HIV https:\/\/www.bashh.org\/resources\/21\/bacterial_vaginosis_2012 (2012).","DOI":"10.12968\/indn.2012.2.4.90782"},{"key":"626_CR276","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1093\/cid\/ciac021","volume":"74","author":"CA Muzny","year":"2022","unstructured":"Muzny, C. A. et al. Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infections treatment guidelines. Clin. Infect. Dis. 74, S144\u2013S151 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR277","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1086\/514725","volume":"28","author":"MR Joesoef","year":"1999","unstructured":"Joesoef, M. R., Schmid, G. P. & Hillier, S. L. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin. Infect. Dis. 28, S57\u2013S65 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR278","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/OLQ.0000000000001178","volume":"47","author":"CA Muzny","year":"2020","unstructured":"Muzny, C. A. & Kardas, P. A narrative review of current challenges in the diagnosis and management of bacterial vaginosis. Sex. Transm. Dis. 47, 441\u2013446 (2020).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR279","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1093\/cid\/ciaa1903","volume":"73","author":"JR Schwebke","year":"2021","unstructured":"Schwebke, J. R. et al. Treatment of male sexual partners of women with bacterial vaginosis: a randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 73, e672\u2013e679 (2021). Important randomized controlled trial that addressed the limitations of past partner trials, but found that randomizing male partners to oral metronidazole at the time the female partner was treated with oral metronidazole did not significantly reduce bacterial vaginosis recurrence over 16\u2009weeks.","journal-title":"Clin. Infect. Dis."},{"key":"626_CR280","doi-asserted-by":"publisher","unstructured":"Oduyebo, O. O., Anorlu, R. I. & Ogunsola, F. T. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD006055.pub2 (2009).","DOI":"10.1002\/14651858.CD006055.pub2"},{"key":"626_CR281","doi-asserted-by":"publisher","first-page":"211 e211","DOI":"10.1016\/j.ajog.2010.10.898","volume":"204","author":"JR Schwebke","year":"2011","unstructured":"Schwebke, J. R. & Desmond, R. A. Tinidazole vs metronidazole for the treatment of bacterial vaginosis. Am. J. Obst. Gyn. 204, 211 e211\u2013211.e216 (2011).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR282","first-page":"705692","volume":"2010","author":"JM Bohbot","year":"2010","unstructured":"Bohbot, J. M., Vicaut, E., Fagnen, D. & Brauman, M. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole. Infect. Dis. Obst. Gyn. 2010, 705692 (2010).","journal-title":"Infect. Dis. Obst. Gyn."},{"key":"626_CR283","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/OLQ.0000000000000300","volume":"42","author":"JR Schwebke","year":"2015","unstructured":"Schwebke, J. R., Marrazzo, J., Beelen, A. P. & Sobel, J. D. A phase 3, multicenter, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis. Sex. Transm. Dis. 42, 376\u2013381 (2015).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR284","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10647440500148321","volume":"13","author":"S Faro","year":"2005","unstructured":"Faro, S., Skokos, C. K. & Clindesse Investigators, G. The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis. Infect. Dis. Obst. Gyn. 13, 155\u2013160 (2005).","journal-title":"Infect. Dis. Obst. Gyn."},{"key":"626_CR285","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/OLQ.0000000000001420","volume":"48","author":"S Surapaneni","year":"2021","unstructured":"Surapaneni, S., Akins, R. & Sobel, J. D. Recurrent bacterial vaginosis: an unmet therapeutic challenge. Experience with a combination pharmacotherapy long-term suppressive regimen. Sex. Transm. Dis. 48, 761\u2013765 (2021).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR286","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2147\/IJWH.S383333","volume":"15","author":"CA Muzny","year":"2023","unstructured":"Muzny, C. A. & Sobel, J. D. Understanding and preventing recurring bacterial vaginosis: important considerations for clinicians. Int. J. Women\u2019s Health 15, 1317\u20131325 (2023).","journal-title":"Int. J. Women\u2019s Health"},{"key":"626_CR287","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.2147\/IDR.S213853","volume":"12","author":"JD Sobel","year":"2019","unstructured":"Sobel, J. D. et al. Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses. Infect. Drug Resist. 12, 2297\u20132307 (2019).","journal-title":"Infect. Drug Resist."},{"key":"626_CR288","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0002-9378(95)90567-7","volume":"172","author":"P Burtin","year":"1995","unstructured":"Burtin, P., Taddio, A., Ariburnu, O., Einarson, T. R. & Koren, G. Safety of metronidazole in pregnancy: a meta-analysis. Am. J. Obst. Gyn. 172, 525\u2013529 (1995).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR289","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/01.AOG.0000216197.26783.b5","volume":"107","author":"GG Nahum","year":"2006","unstructured":"Nahum, G. G., Uhl, K. & Kennedy, D. L. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obst. Gyn. 107, 1120\u20131138 (2006).","journal-title":"Obst. Gyn."},{"key":"626_CR290","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0020-7292(03)00259-5","volume":"83","author":"AE Czeizel","year":"2003","unstructured":"Czeizel, A. E., Kazy, Z. & Vargha, P. Oral tinidazole treatment during pregnancy and teratogenesis. Int. J. Gyn. Obst. 83, 305\u2013306 (2003).","journal-title":"Int. J. Gyn. Obst."},{"key":"626_CR291","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jama.1985.03360080058029","volume":"254","author":"J Swedberg","year":"1985","unstructured":"Swedberg, J., Steiner, J. F., Deiss, F., Steiner, S. & Driggers, D. A. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA 254, 1046\u20131049 (1985).","journal-title":"JAMA"},{"key":"626_CR292","first-page":"163","volume":"28","author":"MB Mengel","year":"1989","unstructured":"Mengel, M. B. et al. The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis. J. Fam. Pract. 28, 163\u2013171 (1989).","journal-title":"J. Fam. Pract."},{"key":"626_CR293","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1471-0528.1988.tb06581.x","volume":"95","author":"M Vejtorp","year":"1988","unstructured":"Vejtorp, M. et al. Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner. Br. J. Obst. Gyn. 95, 920\u2013926 (1988).","journal-title":"Br. J. Obst. Gyn."},{"key":"626_CR294","first-page":"263","volume":"65","author":"H Moi","year":"1989","unstructured":"Moi, H. et al. Should male consorts of women with bacterial vaginosis be treated? Genitourin. Med. 65, 263\u2013268 (1989).","journal-title":"Genitourin. Med."},{"key":"626_CR295","first-page":"550","volume":"82","author":"T Vutyavanich","year":"1993","unstructured":"Vutyavanich, T., Pongsuthirak, P., Vannareumol, P., Ruangsri, R. A. & Luangsook, P. A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obst. Gyn. 82, 550\u2013554 (1993).","journal-title":"Obst. Gyn."},{"key":"626_CR296","first-page":"267","volume":"73","author":"E Colli","year":"1997","unstructured":"Colli, E., Landoni, M. & Parazzini, F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin. Med. 73, 267\u2013270 (1997).","journal-title":"Genitourin. Med."},{"key":"626_CR297","volume":"10","author":"J Amaya-Guio","year":"2016","unstructured":"Amaya-Guio, J., Viveros-Carreno, D. A., Sierra-Barrios, E. M., Martinez-Velasquez, M. Y. & Grillo-Ardila, C. F. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Database Syst. Rev. 10, CD011701 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"626_CR298","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/OLQ.0b013e3182631d89","volume":"39","author":"SD Mehta","year":"2012","unstructured":"Mehta, S. D. Systematic review of randomized trials of treatment of male sexual partners for improved bacterial vaginosis outcomes in women. Sex. Transm. Dis. 39, 822\u2013830 (2012). Comprehensive systematic review of male-partner-treatment trials before 2012 that concluded the systematic limitations of these trials rendered their findings inconclusive and did not provide evidence that bacterial vaginosis was not sexually transmitted.","journal-title":"Sex. Transm. Dis."},{"key":"626_CR299","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1093\/cid\/ciaa1907","volume":"73","author":"LA Vodstrcil","year":"2021","unstructured":"Vodstrcil, L. A. & Bradshaw, C. S. Does partner treatment impact on bacterial vaginosis cure? Clin. Infect. Dis. 73, e680\u2013e682 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR300","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/OLQ.0b013e318214b82d","volume":"38","author":"E Bukusi","year":"2011","unstructured":"Bukusi, E. et al. Topical penile microbicide use by men to prevent recurrent bacterial vaginosis in sex partners: a randomized clinical trial. Sex. Transm. Dis. 38, 483\u2013489 (2011).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR301","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05563-w","volume":"20","author":"LA Vodstrcil","year":"2020","unstructured":"Vodstrcil, L. A. et al. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence. BMC Infect. Dis. 20, 834 (2020).","journal-title":"BMC Infect. Dis."},{"key":"626_CR302","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1056\/NEJMe2500373","volume":"392","author":"CA Muzny","year":"2025","unstructured":"Muzny, C. A. & Sobel, J. D. Bacterial vaginosis \u2014 time to treat male partners. N. Engl. J. Med. 392, 1026\u20131027 (2025).","journal-title":"N. Engl. J. Med."},{"key":"626_CR303","unstructured":"Early clinical trials with live biotherapeutic products: chemistry, manufacturing and control information: guidance for industry. US Department of Health and Human Services https:\/\/www.fda.gov\/files\/vaccines,%20blood%20%26%20biologics\/published\/Early-Clinical-Trials-With-Live-Biotherapeutic-Products--Chemistry--Manufacturing--and-Control-Information--Guidance-for-Industry.pdf (2016)."},{"key":"626_CR304","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.938838","volume":"9","author":"WK Chieng","year":"2022","unstructured":"Chieng, W. K. et al. Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? A systematic review and meta-analysis of randomized controlled trials. Front. Nutr. 9, 938838 (2022).","journal-title":"Front. Nutr."},{"key":"626_CR305","first-page":"90","volume":"26","author":"HF Liu","year":"2022","unstructured":"Liu, H. F. & Yi, N. A systematic review and meta-analysis on the efficacy of probiotics for bacterial vaginosis. Eur. Rev. Med. Pharmacol. Sci. 26, 90\u201398 (2022).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"626_CR306","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/jcm10071461","volume":"10","author":"A Lopez-Moreno","year":"2021","unstructured":"Lopez-Moreno, A. & Aguilera, M. Vaginal probiotics for reproductive health and related dysbiosis: systematic review and meta-analysis. J. Clin. Med. 10, 1461 (2021).","journal-title":"J. Clin. Med."},{"key":"626_CR307","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/1471-0528.15870","volume":"127","author":"J van de Wijgert","year":"2020","unstructured":"van de Wijgert, J. & Verwijs, M. C. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs. BJOG 127, 287\u2013299 (2020).","journal-title":"BJOG"},{"key":"626_CR308","volume":"16","author":"AM Zuniga Vinueza","year":"2024","unstructured":"Zuniga Vinueza, A. M. Probiotics for the prevention of vaginal infections: a systematic review. Cureus 16, e64473 (2024).","journal-title":"Cureus"},{"key":"626_CR309","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/OLQ.0b013e3182267ac4","volume":"38","author":"BM Ngugi","year":"2011","unstructured":"Ngugi, B. M. et al. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05. Sex. Transm. Dis. 38, 1020\u20131027 (2011).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR310","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439176","volume":"15","author":"M Karimi","year":"2024","unstructured":"Karimi, M. et al. Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Front. Immunol. 15, 1439176 (2024).","journal-title":"Front. Immunol."},{"key":"626_CR311","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1001\/jama.2014.13875","volume":"312","author":"I Youngster","year":"2014","unstructured":"Youngster, I. et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312, 1772\u20131778 (2014).","journal-title":"JAMA"},{"key":"626_CR312","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41591-019-0600-6","volume":"25","author":"A Lev-Sagie","year":"2019","unstructured":"Lev-Sagie, A. et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat. Med. 25, 1500\u20131504 (2019). First exploratory study to test the use of vaginal microbiome transplantation from healthy donors as therapeutic intervention for bacterial vaginosis, providing a proof of concept for further randomized controlled trials.","journal-title":"Nat. Med."},{"key":"626_CR313","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102070","volume":"61","author":"T Wronding","year":"2023","unstructured":"Wronding, T. et al. Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution and live birth after recurrent pregnancy loss: a proof of concept case study. eClinicalMedicine 61, 102070 (2023).","journal-title":"eClinicalMedicine"},{"key":"626_CR314","doi-asserted-by":"publisher","unstructured":"Bosma, E. F. et al. Antibiotic-free vaginal microbiota transplantation (VMT) changes vaginal microbiota and immune profile in women with asymptomatic dysbiosis \u2014 reporting of a randomized, placebo-controlled trial. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2024.06.25.24309408 (2024).","DOI":"10.1101\/2024.06.25.24309408"},{"key":"626_CR315","doi-asserted-by":"publisher","unstructured":"Wr\u00f8nding, T. et al. Vaginal microbiota transplantation (VMT) for treatment of vaginal dysbiosis without the use of antibiotics \u2014 a double-blinded randomized controlled trial in healthy women with vaginal dysbiosis. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2024.06.28.24309465 (2024).","DOI":"10.1101\/2024.06.28.24309465"},{"key":"626_CR316","unstructured":"Hussain, F. A. et al. Pilot data from the first double-blind placebo-controlled vaginal microbiota transplantation trial. In SRI 2024: Scientific Program & Abstracts 101A\u00a0(Society for Reproductive Investigation, 2024)."},{"key":"626_CR317","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fcimb.2019.00306","volume":"9","author":"K DeLong","year":"2019","unstructured":"DeLong, K. et al. Conceptual design of a universal donor screening approach for vaginal microbiota transplant. Front. Cell Infect. Microbiol. 9, 306 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"626_CR318","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22873-y","volume":"12","author":"LJ Yockey","year":"2022","unstructured":"Yockey, L. J. et al. Screening and characterization of vaginal fluid donations for vaginal microbiota transplantation. Sci. Rep. 12, 17948 (2022).","journal-title":"Sci. Rep."},{"key":"626_CR319","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246953","volume":"16","author":"EL Plummer","year":"2021","unstructured":"Plummer, E. L. et al. Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: a systematic review. PLoS ONE 16, e0246953 (2021).","journal-title":"PLoS ONE"},{"key":"626_CR320","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12905-023-02303-5","volume":"23","author":"JDC Ross","year":"2023","unstructured":"Ross, J. D. C. et al. Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial. BMC Women\u2019s Health 23, 241 (2023).","journal-title":"BMC Women\u2019s Health"},{"key":"626_CR321","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2022.915948","volume":"4","author":"D Tyssen","year":"2022","unstructured":"Tyssen, D. et al. The impact of over-the-counter lactic acid containing vaginal gels on the integrity and inflammatory state of the vaginal epithelium in vitro. Front. Reprod. Health 4, 915948 (2022).","journal-title":"Front. Reprod. Health"},{"key":"626_CR322","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/microorganisms12071500","volume":"12","author":"JD Cate","year":"2024","unstructured":"Cate, J. D., Sullivan, Y. Z. & King, M. D. Inhibition of microbial growth and biofilm formation in pure and mixed bacterial samples. Microorganisms 12, 1500 (2024).","journal-title":"Microorganisms"},{"key":"626_CR323","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1017\/S0022215118000932","volume":"132","author":"CK Youn","year":"2018","unstructured":"Youn, C. K. et al. Comparative efficacies of topical antiseptic eardrops against biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa. J. Laryngol. Otol. 132, 519\u2013522 (2018).","journal-title":"J. Laryngol. Otol."},{"key":"626_CR324","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/OLQ.0000000000001063","volume":"46","author":"A Powell","year":"2019","unstructured":"Powell, A. et al. Clinicians\u2019 use of intravaginal boric acid maintenance therapy for recurrent vulvovaginal candidiasis and bacterial vaginosis. Sex. Transm. Dis. 46, 810\u2013812 (2019).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR325","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1089\/jwh.2010.2708","volume":"20","author":"C Iavazzo","year":"2011","unstructured":"Iavazzo, C., Gkegkes, I. D., Zarkada, I. M. & Falagas, M. E. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. J. Women\u2019s Health 20, 1245\u20131255 (2011).","journal-title":"J. Women\u2019s Health"},{"key":"626_CR326","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/cid\/ciy554","volume":"68","author":"JM Marrazzo","year":"2019","unstructured":"Marrazzo, J. M. et al. Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: a randomized, single-blind, phase 2, controlled trial. Clin. Infect. Dis. 68, 803\u2013809 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"626_CR327","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/OLQ.0b013e3181b08456","volume":"36","author":"O Reichman","year":"2009","unstructured":"Reichman, O., Akins, R. & Sobel, J. D. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex. Transm. Dis. 36, 732\u2013734 (2009).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR328","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1097\/OLQ.0000000000001562","volume":"48","author":"R Mittelstaedt","year":"2021","unstructured":"Mittelstaedt, R. et al. Data on safety of intravaginal boric acid use in pregnant and nonpregnant women: a narrative review. Sex. Transm. Dis. 48, e241\u2013e247 (2021).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR329","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.8606","volume":"7","author":"KA Carter","year":"2024","unstructured":"Carter, K. A., Tuddenham, S. & Brotman, R. M. Dequalinium chloride \u2014 an emerging option in the sparse landscape of bacterial vaginosis therapies. JAMA Netw. Open. 7, e248606 (2024).","journal-title":"JAMA Netw. Open."},{"key":"626_CR330","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.8661","volume":"7","author":"G Raba","year":"2024","unstructured":"Raba, G. et al. Efficacy of dequalinium chloride vs metronidazole for the treatment of bacterial vaginosis: a randomized clinical trial. JAMA Netw. Open. 7, e248661 (2024).","journal-title":"JAMA Netw. Open."},{"key":"626_CR331","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/LGT.0000000000000790","volume":"28","author":"F Eckel","year":"2024","unstructured":"Eckel, F., Farr, A., Deinsberger, J., Kernmayer-Farr, K. & Foessleitner, P. Dequalinium chloride for the treatment of vulvovaginal infections: a systematic review and meta-analysis. J. Lower Genit. Tract. Dis. 28, 76\u201383 (2024).","journal-title":"J. Lower Genit. Tract. Dis."},{"key":"626_CR332","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-148","volume":"12","author":"H Verstraelen","year":"2012","unstructured":"Verstraelen, H., Verhelst, R., Roelens, K. & Temmerman, M. Antiseptics and disinfectants for the treatment of bacterial vaginosis: a systematic review. BMC Infect. Dis. 12, 148 (2012).","journal-title":"BMC Infect. Dis."},{"key":"626_CR333","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejogrb.2019.11.032","volume":"245","author":"SE Chavoustie","year":"2020","unstructured":"Chavoustie, S. E. et al. Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% gel for the treatment of bacterial vaginosis. Eur. J. Obst. Gyn. Reprod. Biol. 245, 13\u201318 (2020).","journal-title":"Eur. J. Obst. Gyn. Reprod. Biol."},{"key":"626_CR334","volume":"10","author":"JR Schwebke","year":"2021","unstructured":"Schwebke, J. R. et al. A phase 3, randomized, controlled trial of Astodrimer 1% gel for preventing recurrent bacterial vaginosis. Eur. J. Obst. Gyn. Reprod. Biol. X 10, 100121 (2021).","journal-title":"Eur. J. Obst. Gyn. Reprod. Biol. X"},{"key":"626_CR335","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02319-21","volume":"66","author":"C Landlinger","year":"2022","unstructured":"Landlinger, C. et al. Preclinical data on the Gardnerella-specific endolysin PM-477 indicate its potential to improve the treatment of bacterial vaginosis through enhanced biofilm removal and avoidance of resistance. Antimicrob. Agents Chemother. 66, e0231921 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"626_CR336","unstructured":"US National Library of Medicine ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/study\/NCT06469164 (2025)."},{"key":"626_CR337","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12905-023-02260-z","volume":"23","author":"J Brusselmans","year":"2023","unstructured":"Brusselmans, J., De Sutter, A., Devleesschauwer, B., Verstraelen, H. & Cools, P. Scoping review of the association between bacterial vaginosis and emotional, sexual and social health. BMC Women\u2019s Health 23, 168 (2023).","journal-title":"BMC Women\u2019s Health"},{"key":"626_CR338","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224964","volume":"14","author":"J Anstey Watkins","year":"2019","unstructured":"Anstey Watkins, J. et al. Acceptability of and treatment preferences for recurrent bacterial vaginosis-topical lactic acid gel or oral metronidazole antibiotic: qualitative findings from the VITA trial. PLoS ONE 14, e0224964 (2019).","journal-title":"PLoS ONE"},{"key":"626_CR339","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173637","volume":"12","author":"JE Bilardi","year":"2017","unstructured":"Bilardi, J. E. et al. Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis. PLoS ONE 12, e0173637 (2017).","journal-title":"PLoS ONE"},{"key":"626_CR340","volume":"19","author":"K Thomas-White","year":"2023","unstructured":"Thomas-White, K. et al. Psychosocial impact of recurrent urogenital infections: a review. Women\u2019s Health 19, 17455057231216537 (2023).","journal-title":"Women\u2019s Health"},{"key":"626_CR341","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151794","volume":"11","author":"J Bilardi","year":"2016","unstructured":"Bilardi, J. et al. Women\u2019s management of recurrent bacterial vaginosis and experiences of clinical care: a qualitative study. PLoS ONE 11, e0151794 (2016).","journal-title":"PLoS ONE"},{"key":"626_CR342","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1745-7599.2009.00474.x","volume":"22","author":"SC Payne","year":"2010","unstructured":"Payne, S. C., Cromer, P. R., Stanek, M. K. & Palmer, A. A. Evidence of African\u2013American women\u2019s frustrations with chronic recurrent bacterial vaginosis. J. Am. Acad. Nurse Pract. 22, 101\u2013108 (2010).","journal-title":"J. Am. Acad. Nurse Pract."},{"key":"626_CR343","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12905-023-02236-z","volume":"23","author":"K Chow","year":"2023","unstructured":"Chow, K. et al. Impact of (recurrent) bacterial vaginosis on quality of life and the need for accessible alternative treatments. BMC Women\u2019s Health 23, 112 (2023).","journal-title":"BMC Women\u2019s Health"},{"key":"626_CR344","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ajog.2004.02.015","volume":"190","author":"DV Landers","year":"2004","unstructured":"Landers, D. V., Wiesenfeld, H. C., Heine, R. P., Krohn, M. A. & Hillier, S. L. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am. J. Obst. Gyn. 190, 1004\u20131010 (2004).","journal-title":"Am. J. Obst. Gyn."},{"key":"626_CR345","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0029-7844(96)00233-5","volume":"88","author":"JR Schwebke","year":"1996","unstructured":"Schwebke, J. R., Hillier, S. L., Sobel, J. D., McGregor, J. A. & Sweet, R. L. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obst. Gyn. 88, 573\u2013576 (1996).","journal-title":"Obst. Gyn."},{"key":"626_CR346","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/LGT.0b013e318033dfed","volume":"11","author":"BE Sha","year":"2007","unstructured":"Sha, B. E. et al. Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis. J. Lower Genit. Tract. Dis. 11, 240\u2013250 (2007).","journal-title":"J. Lower Genit. Tract. Dis."},{"key":"626_CR347","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037818","volume":"7","author":"S Srinivasan","year":"2012","unstructured":"Srinivasan, S. et al. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS ONE 7, e37818 (2012).","journal-title":"PLoS ONE"},{"key":"626_CR348","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.2147\/IDR.S364229","volume":"15","author":"M Ahmed","year":"2022","unstructured":"Ahmed, M., Admassu Ayana, D. & Abate, D. Bacterial vaginosis and associated factors among pregnant women attending antenatal care in Harar city, Eastern Ethiopia. Infect. Drug. Resist. 15, 3077\u20133086 (2022).","journal-title":"Infect. Drug. Resist."},{"key":"626_CR349","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-5-12","volume":"5","author":"E Demba","year":"2005","unstructured":"Demba, E. et al. Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in the Gambia, West Africa. BMC Infect. Dis. 5, 12 (2005).","journal-title":"BMC Infect. Dis."},{"key":"626_CR350","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijgo.2007.03.010","volume":"98","author":"A Karani","year":"2007","unstructured":"Karani, A. et al. The Pap smear for detection of bacterial vaginosis. Int. J. Gyn. Obst. 98, 20\u201323 (2007).","journal-title":"Int. J. Gyn. Obst."},{"key":"626_CR351","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/humrep\/deab002","volume":"36","author":"EM Lokken","year":"2021","unstructured":"Lokken, E. M. et al. Association between bacterial vaginosis and fecundability in Kenyan women planning pregnancies: a prospective preconception cohort study. Hum. Reprod. 36, 1279\u20131287 (2021).","journal-title":"Hum. Reprod."},{"key":"626_CR352","doi-asserted-by":"publisher","first-page":"130","DOI":"10.18683\/germs.2023.1376","volume":"13","author":"S Rezk","year":"2023","unstructured":"Rezk, S. & Alqabbasi, O. Bacterial vaginosis, vulvovaginal candidiasis, trichomonal vaginitis and aerobic vaginitis in women from Egypt. Germs 13, 130\u2013136 (2023).","journal-title":"Germs"},{"key":"626_CR353","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00007435-200306000-00003","volume":"30","author":"B West","year":"2003","unstructured":"West, B. et al. Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in the Gambia. Sex. Transm. Dis. 30, 483\u2013489 (2003).","journal-title":"Sex. Transm. Dis."},{"key":"626_CR354","doi-asserted-by":"publisher","unstructured":"Bansal, R., Garg, P. & Garg, A. Comparison of Amsel\u2019s criteria and Nugent\u2019s criteria for diagnosis of bacterial vaginosis in tertiary care centre. Int. J. Reprod. Contracept. Obst. Gyn. https:\/\/doi.org\/10.18203\/2320-1770.ijrcog20190297 (2019).","DOI":"10.18203\/2320-1770.ijrcog20190297"},{"key":"626_CR355","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06562-1","volume":"21","author":"R Bhujel","year":"2021","unstructured":"Bhujel, R., Mishra, S. K., Yadav, S. K., Bista, K. D. & Parajuli, K. Comparative study of Amsel\u2019s criteria and Nugent scoring for diagnosis of bacterial vaginosis in a tertiary care hospital, Nepal. BMC Infect. Dis. 21, 825 (2021).","journal-title":"BMC Infect. Dis."},{"key":"626_CR356","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1071\/SH21149","volume":"18","author":"A Challa","year":"2022","unstructured":"Challa, A. et al. Diagnostic concordance between Amsel\u2019s criteria and the Nugent scoring method in the assessment of bacterial vaginosis. Sex. Health 18, 512\u2013514 (2022).","journal-title":"Sex. Health"},{"key":"626_CR357","volume":"2014","author":"P Madhivanan","year":"2014","unstructured":"Madhivanan, P. et al. Performance of BVBlue rapid test in detecting bacterial vaginosis among women in Mysore, India. Infect. Dis. Obst. Gyn. 2014, 908313 (2014).","journal-title":"Infect. Dis. Obst. Gyn."},{"key":"626_CR358","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/ijstd.ijstd_67_21","volume":"43","author":"R Mala","year":"2022","unstructured":"Mala, R., Sood, S., Kapil, A., Gupta, S. & Singh, N. Comparison of Amsel\u2019s criteria with low and high Nugent\u2019s scores for the diagnosis of bacterial vaginosis. Ind. J. Sex. Transm. Dis. AIDS 43, 56\u201358 (2022).","journal-title":"Ind. J. Sex. Transm. Dis. AIDS"},{"key":"626_CR359","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3855\/jidc.1153","volume":"5","author":"T Modak","year":"2011","unstructured":"Modak, T. et al. Diagnosis of bacterial vaginosis in cases of abnormal vaginal discharge: comparison of clinical and microbiological criteria. J. Infect. Dev. Countries 5, 353\u2013360 (2011).","journal-title":"J. Infect. Dev. Countries"},{"key":"626_CR360","doi-asserted-by":"publisher","unstructured":"King, A. J. et al. Getting everyone on board to break the cycle of bacterial vaginosis (BV) recurrence: a qualitative study of partner treatment for BV. Patient https:\/\/doi.org\/10.1007\/s40271-025-00731-z (2025).","DOI":"10.1007\/s40271-025-00731-z"}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-025-00626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-025-00626-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-025-00626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T03:02:53Z","timestamp":1750302173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-025-00626-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":360,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1038\/s41572-025-00626-1","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"14 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.S.B. received research grant support to her institution from the Australian National Health and Medical Council and Australian Research Council. C.S.B. has been an adviser to Abbott Pty Ltd, serves on a number of technical advisory groups of The World Health Organisation and is a board member of the International Society for STD Research. M.M.H.-K. is on the scientific advisory board for Freya Biosciences. D.N.F. receives a royalty from BD for intellectual property (Institution: Fred Hutchinson Cancer Center. Inventors: David Fredricks and Tina Fiedler. US patent: US 7,625,704 B2. Status: issued. Aspect of patent related to manuscript: molecular methods for diagnosis of bacterial vaginosis). D.N.F. is also an officer in the MetaboliteDx corporation. C.A.M. received research grant support to her institution from NIH\/NIAID, Lupin Pharmaceuticals, Gilead Sciences, Inc., BioNTech, and Abbott Molecular. C.A.M. also reports consulting fees from Abbott, BioNTech, bioMerieux and Cepheid; honoraria from Abbott, Roche, Elsevier and the Merck Manuals; and royalties from UpToDate. C.M.M. receives royalties from UpToDate and serves on the Scientific Advisory Boards of Concerto Bio, and Ancilia Biosciences. C.M.M. also has a financial interest in Ancilia Biosciences, a company developing a new class of Live Biotherapeutics and other bacterial products. C.M.M.\u2019s interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham in accordance with their conflict-of-interest policies. L.A.V. and E.L.P. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}